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ABSTRACT 
 
DESIGN OF DRUG NANO-CARRIERS FOR STUDY OF MULTIDRUG RESISTANCE 
IN SINGLE LIVE CELLS 
Pavan Kumar Cherukuri 
Old Dominion University, 2016  
 Director: Dr. Xiao-Hong Nancy Xu  
 
Multidrug resistance (MDR) exists in both prokaryotic and eukaryotic cells. MDR 
is responsible for ineffective treatment of a wide range of diseases, such as infections 
and cancer. The ATP-binding cassette (ABC) membrane transporters (efflux pumps) 
are one of the largest and most diverse super-families of membrane proteins found in all 
living organisms, ranging from bacteria to humans. All ABC transporters share a 
common structure of four core domains; two transmembrane domains (TMD) with 
variable sequence and topology and two nucleotide-binding domains (NBD) with 
conserved sequences. Conventional methods for the study of the efflux functions are 
radioactively labeled substrates and fluorescent dyes, which provide the sum of 
accumulation kinetics of a population of cells. Notably, individual cells act independently 
of efflux and accumulation kinetics and therefore, the accumulation kinetics of single 
cells is lost in such bulk measurements. Furthermore, single fluorophores or 
radioisotopes themselves do not possess distinctive size-dependent physicochemical 
properties that would allow their sizes to be measured in situ in real time. Therefore, 
they cannot serve as various sized pump substrates for the study of size-dependent 
efflux function of single membrane transporters in single live cells. This dissertation 
focuses on development of single nanoparticle (NP) plasmonic spectroscopy and 
design of three different sized drug nano-carriers to study the size-dependent efflux 
function of ABC membrane transporters (e.g., MsbA and BmrA) in single live cells, two 
model organisms such as E.coli (gram-negative) and B.subtilis (gram-positive) bacterial 
cells., aiming to understand and overcome MDR. We designed, synthesized, and 
purified silver (Ag) nanoparticles (NPs) with diameters of 2.4 ± 0.7 nm, 13.0 ± 3.1, and 
92.6 ± 4.4 nm, functionalized them with monolayer of 11-amino-1-undecanethiol 
hydrochloride (MUNH2), and linked them with antibiotics ofloxacin (Oflx) via two-step 
 
 
reaction process. We determined the conjugation ratio (the number of Oflx molecules 
attached to a single NP) of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as 8.6x102, 9.4x103, 
and 6.5x105 respectively. We characterized single nano-carriers using dark-field optical 
microscopy and spectroscopy (DFOMS). These drug nano-carriers exhibit 
photostability, which enabled us to study the size-dependent efflux functions of single 
membrane transporters in single live cells in real-time for a desired period of time. Using 
these three different sized nano-carriers, we found the size dependent inhibitory effects 
of the drug nano-carriers in single live cells, two strains of B.subtilis, WT (normal 
expression of BmrA) and ∆BmrA (deletion of BmrA). We have demonstrated that single 
plasmonic NPs can serve as unique size-dependent molecular imaging probes to study 
efflux functions of single membrane transporters in single live cells in real-time. 
Furthermore, we found that the smaller drug nano-carriers are much more 
biocompatible than the larger drug nano-carriers. In other words, the larger drug nano-
carriers show higher inhibitory effects against the bacterial cells. Thus, the smallest 
nano-carriers (2.4 ± 0.7 nm) could be used to study the efflux function of ABC (BmrA) 
membrane transporters in single live cells, while the large nano-carriers could be used 
to effectively deliver antibiotics that could overcome MDR and enhance antibiotics 
efficacy. 
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NOMENCLATURE 
ΔABM B.subtlis mutant strain with no expression of BmrA proteins 
Ε Extinction coefficient 
λmax  Peak wavelength 
µmol Micromoles 
µm Micrometer 
µM Micromolar 
µL Microliter 
ABC ATP-binding cassette 
Ag NPs Silver Nanoparticles 
Ag  Silver 
AgMUNH2 Silver nanoparticles functionalized with 11-amino undecanethiol  
 Hydrochloride 
AgMUNH-
Oflx 
Silver nanoparticles functionalized with 11-amino undecanethiol  
 hydrochloride and linked to ofloxacin 
Au Gold  
AZT Aztreonam 
C Concentration 
CCD Charged coupled device used for imaging nanoparticles with high  
 sensitivity, temporal resolution and spatial resolution 
DFOMS   Dark-field optical microscopy and spectroscopy 
DI De-ionized 
DLS Dynamic light scattering 
viii 
 
 
DNA Deoxyribonucleic acid 
EDC 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide Hydrochloride 
EtBr Ethidium Bromide 
FWHM Full width at half maxima 
h Hour 
H2O2 Hydrogen peroxide 
HRTEM High-resolution transmission electron microscopy 
LB Luria medium 
LSPRS Localized surface plasmonic resonance spectra 
MΩ Megaohms 
min Minutes 
mL Milliliter 
ms Millisecond 
MIC50 Minimum inhibitory concentration at 50% 
MDR  Multidrug resistance pump 
MUNH2  11-amino undecanethiol hydrochloride 
nM Nanomolar 
nm Nanometer 
ns Nanosecond 
NaBH4 Sodium borohydride 
s-NHS N-hydroxysulfosuccinimide 
NBD Nucleotide-binding domains 
NPs Nanoparticles 
OD Optical Density 
Oflx Ofloxacin 
ix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pM Picomolar 
PBS Phosphate buffer saline 
PVP Polyvinyl pyrrolidine 
rcf relative centrifugal force 
s Seconds 
SMNOBS Single Molecule Nanoparticle Optical probes and biosensors 
TEM Transmission electron microscopy 
TMD Transmembrane domains 
UV-vis Ultraviolet-visible 
WT Wild type 
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CHAPTER I 
OVERVIEW 
Multidrug membrane transporters (efflux pumps) are found in both prokaryotes 
and eukaryotes and they can extrude a wide variety of substrates out of cells, leading to 
multidrug resistance (MDR) and ineffective treatment of wide range of diseases, from 
cancer to infection diseases.1-2 For instance, the adenosine triphosphate (ATP)-binding 
cassette (ABC) transporters (e.g., MsbA, BmrA) is one of the largest and most diverse 
super-families of membrane transporters found in all living organisms, ranging from 
bacteria to humans.1, 3-5 All ABC transporters share a common structure of a four core 
domain; two transmembrane domains (TMD) and two nucleotide-binding domains 
(NBD).1, 5 Despite extensive studies, many questions about their molecular mechanisms 
and functions remain unanswered. The current method for studying the efflux function 
includes the use of radioactively labeled substrates (14C and 3H) and fluorescent dyes 
(Ethidium bromide or Hoechst dyes) as probes.6-9 These conventional methods enable 
to study the accumulation of bulk cells. Notably, individual membrane transporters act 
distinctively and so do their efflux pump kinetics. We have demonstrated that efflux 
kinetics of single membrane transporters of single live cells can be studied in real-time 
using thin-layer total-internal reflection fluorescence microscopy and spectroscopy.10 
However, single fluorophores or radioisotopes themselves do not possess distinctive 
size-dependent physicochemical properties that would allow their sizes to be measured 
in situ in real time. Therefore, they cannot be used as various sized pump substrates for 
the study of size-dependent efflux function of single membrane transporters in single 
live cells.  
 
Noble metal nanoparticles, such as Silver nanoparticles (Ag NPs), Gold 
nanoparticles (Au NPs) possess unique optical properties, such as localized surface 
plasmon resonance (LSPR).11-13 Ag NPs show size-dependent plasmonic optical 
properties.11-13 The Ag NPs show orders of magnitude at higher scattering intensity than 
the same sized of Au NPs.11-16 Furthermore, single Ag NPs exhibit much higher size-
dependent localized surface plasmon resonance (LSPR) spectra than Au NPs.11-16 
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   Therefore, Ag NPs are much more sensitive optical imaging probes for the study of 
size-dependent efflux kinetics of membrane transporters in single live cells than the Au 
NPs. We have used the size-dependent LSPR spectra (colors) of single Ag NPs to 
image the sizes of NPs in solution, single live cells, and embryos at nm resolution in real 
time.13, 16-20  
  
Unlike fluorescent probes and semiconductor quantum dots (QDs), these noble 
metal NPs show photostability and resist photodecomposition and blinking. They can 
serve as optical probes for tracking the transformation of pore sizes of membrane 
transporters and the size-dependent transport kinetics of efflux pumps for a desired 
period of time.17-19 
    
   This dissertation consists of seven chapters. Chapter I, provides a brief overview of 
the research background, the significance of this dissertation research, and an outline of 
the contents pertaining to each individual chapter.  
 
   Chapter II, discusses the synthesis and characterization of stable (non-aggregated) 
spherical Ag NPs. We have demonstrated that single Ag NPs resist to photo-bleaching 
and they can serve as photostable imaging probes to study efflux kinetics and function 
of multidrug membrane transporter in gram-negative bacteria cells (E.coli) at single cell 
resolution and over a desired long period of time. 
 
We synthesized and characterized purified and stable Ag NPs (12.3 ± 1.8 nm in 
diameter) and used them to study efflux kinetics and function of multidrug membrane 
transporters (MsbA). The distinctive LSPR spectra (colors) of single Ag NPs enable us 
to distinguish single Ag NPs over cellular membranes, vesicles, and debris and to track 
single NPs in and out of single live cells. We found the accumulation and efflux kinetics 
of single Ag NPs to be highly dependent on the concentration of Ag NPs and the 
presence of pump inhibitors (orthovanadate), demonstrating that single Ag NPs can 
serve as probes to study efflux functions of MsbA in single live cells (E.coli).21  
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Figure 1: Schematic illustration of study of efflux kinetics of single MsbA 
transporters in single live cells in real-time using LSPR spectra of single Ag 
NPs.21  
 
In Chapter III, we studied the dependence of inhibitory effects of drug nano-
carriers upon the sizes and doses of the drug nano-carriers and expression level of 
membrane transporters. We were aiming to develop drug nano-carriers to evade the 
transporters and to achieve high efficacy, and rationally design biocompatible nano-
carriers to study efflux function of single membrane transporters. To this end, we 
synthesized three different sizes of Ag NPs (2.4 ± 0.7), (13.0 ± 3.1), and (92.6 ± 4.4) 
nm. We functionalized these NPs with ofloxacin (Oflx) to produce AgMUNH-Oflx NPs 
(drug nano-carriers) by a two-step reaction process. First, a thiol group is used to attach 
monolayer of 11-amino-1-undecanethiol hydrochloride (MUNH2) molecules to produce 
AgMUNH2 NPs, and in step 2 carboxyl group of Oflx is covalently conjugated with the 
amine group of MUNH2 via the peptide bond. We determined the number of Oflx 
molecules attached to a single NP (conjugation ratios) as 8.6x102, 9.4 x103, and 6.5 
x105. We studied the inhibitory effect of drug nano-carriers against B.subtilis, with 
normal expression of BmrA and with deletion of BmrA and found the size and dose 
dependent minimum inhibitory concentration of drug nano-carriers, showing 2.4 ± 0.7 
nm is less toxic than free Oflx (non-Conjugated with NPs), 13.0 ± 3.1, and 92.6 ± 4.4 nm 
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are far more toxic than free Oflx as summarized in Figure 2. In Figure 2 minimum 
inhibitory concentrations were 0.165, 0.126, 0.078, and 0.013 µM for 2.4 ± 0.7 nm, free 
Oflx, 13.0 ± 3.1 nm, and 92.6 ± 4.4 nm and are incubated with different concentrations 
of three sized drug nano-carriers and Oflx alone. We also conducted control 
experiments and found that AgMUNH2 NPs (nano-carriers) are biocompatible and show 
insignificant inhibitory effect against both strains of BmrA.22 
 
 
 
Figure 2: Schematic illustration of MIC of drug nano-carriers in B.subtilis using 
DFOMS. 22 
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In Chapter IV, we studied the efflux function of BmrA in both strains of B.subtilis  
(WT and a devoid pump ΔBmrA) using AgMUNH-Oflx (drug nano-carriers) and 
AgMUNH2 (nano-carrier) NPs. We found that single AgMUNH-Oflx NPs and AgMUNH2 
NPs passively diffused into the live cells and were extruded out of live cells as shown in 
Figure 3. We found that accumulation rates of NPs inside the cells highly depends upon 
the types of NPs, doses of NPs, and expression of BmrA, demonstrating that NPs can 
serve as imaging probes to study efflux function of BmrA and to design effective 
therapy.23  
 
 
Figure 3: Schematic illustration of study of efflux kinetics of single B.subtilis 
transporters in single live cells in real-time using LSPR spectra of single 2.4 ± 0.7 
nm AgMUNH-Oflx NPs.23  
 
 
In Chapter V, we studied efflux function of BmrA in both strains of B.subtilis (WT 
and ΔBmrA) using 13.0 ± 3.1 nm AgMUNH-Oflx NPs and AgMUNH2. We found that 
single AgMUNH-Oflx NPs and AgMUNH2 NPs passively diffused into the live cells and 
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were extruded out of live cells. We found a higher number of intracellular AgMUNH2 
NPs than AgMUNH-Oflx NPs, indicating that the cells highly depend upon the types of 
NPs as shown in Figure 4. We also found that accumulation rates of NPs inside the 
cells highly depend upon the doses of NPs indicating that rapid efflux occurs when 
functionalized with the Oflx drug doses of NPs, and expression of BmrA, demonstrating 
that NPs can serve as effectively deliver drug that could overcome MDR and enhance 
antibiotics efficacy.24 
 
Figure 4: Schematic illustration of study of efflux kinetics of single B.subtilis 
transporters in single live cells in real-time using LSPR spectra of single 13.0 ± 
3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs.
24  
 
 
In Chapter VI, we studied the efflux function of BmrA in both strains of B.subtilis 
(WT and ΔBmrA) using 92.6 ± 4.4 nm of AgMUNH-Oflx NPs and AgMUNH2 NPs. We 
found that single AgMUNH-Oflx NPs and AgMUNH2 NPs are passively diffused into 
cells and are effluxed out bacteria cells as illustrated in Figure 5. We found that 
accumulation rates of NPs inside the cells highly depend up on the doses of NPs, types 
7 
 
 
 
of NPs, and expression of BmrA. This study shows that large NPs functionalized with 
Oflx can enter the drug and be extruded out by BmrA.25 
 
 
 
 
Figure 5: Schematic illustration of study of efflux kinetics of single B.subtilis 
transporters in single live cells in real-time using LSPR spectra of single 92.4 ± 
4.4 nm AgMUNH-Oflx NPs.25  
 
 
Chapter VII, we summarized the research findings described in the previous 
chapters, emphasized the importance of the research, and presented possible future 
research directions. 
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CHAPTER II 
 
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS IN 
SINGLE ESCHERICHIA COLI LIVE CELLS USING SINGLE NANOPARTICLE 
PLASMONIC SPECTROSCOPY 
 
INTRODUCTION 
Multidrug membrane transporters are present in both prokaryotic and eukaryotic 
cells,2 in many cases they are responsible for multidrug resistance (MDR). MDR is a key 
challenge for treatment of diseases, including cancer and infections.26 MDR involves the 
normal efflux out of normal cell substrates, but also can lead to pumping beneficial 
drugs out of the cell.5 MDR transporters are classified into two types. One is energy 
driven ATP-binding cassette (ABC) transporter, and the other uses proton gradients to 
facilitate transport,respectively.26  
 
ATP-binding cassette (ABC) transporters constitute one of the largest and most 
diverse membrane protein super-families found in living organisms and they have been 
conserved across archaea, eubacteria, and eukarya.2, 26 ABC transporters use a high-
affinity solute binding protein which mediates uptake and export of wide variety of 
substrates (ions, sugar, amino acids, proteins, vitamins and drugs) by coupling the 
energy released from ATP hydrolysis.1-2, 26-27 ABC transporters in all living organisms 
share a familiar constitution, comprising two transmembrane domains (TMDs) and two 
cytosolic sites called nucleotide-binding domains (NBDs).2, 26 The TMDs contain several 
hydrophobic segments which span the membrane and form transmembrane channels 
while NBDs acts as a molecular motor which transforms the chemical potential energy 
of ATP into protein conformational changes.2 It is worth noting that the primary 
sequences and topology of ABC transporter TMDs are substantially different among 
organisms, as compared with NBDs which are composed of conserved Walker A and B 
consensus motifs for nucleotide bindings.2 The similar structures and functions of ABC 
transporters suggest similarities of efflux function in bacteria and humans.2 The gram-
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negative bacteria Escherichia coli (E.coli) have an inner membrane, outer membrane 
and periplasmic space.28 E.coli is widely used as a model organism to study multidrug 
membrane transporters since it has the inner membrane protein MsbA.28 The MsbA 
protein is homologous to mammalian multidrug transporter P-glycoproteins (P-gp; 
MDR1; or ABCB1) that are remarkably associated with resistance to anticancer drugs in 
human raising an essential difficulty in cancer therapies.29 
 
The present techniques for studying of efflux function in bacteria and mammalian 
cells including utilizing the measurement of the accumulation of radioactively labeled 
substrates (e.g., 14C and 3H) and fluorescence dyes (e.g., rhodamine 123, Hoechst dye, 
and ethidium bromide).6-9, 30-33 Fluorophores are used to study uptake and efflux kinetics 
because the dyes emit weak fluorescence signals in solution (outside cells) and then 
become strongly fluorescent in hydrophobic environments especially when they enter 
into the cells and intercalate with DNA.6-7 Thus, the accumulation of fluorescence dyes 
has been widely used to investigate efflux functions of membrane transporters by 
measuring the time-dependent (time-course) fluorescence intensity.6-7 However, these 
conventional approaches are unable to probe size-dependent efflux kinetics of 
membrane transports of single living cells because individual cells respond differently to 
various sizes of substrates.34  
 
Metal nanoparticles (NPs) such as Silver (Ag) and Gold (Au) have unique optical 
properties, notably localized surface plasmonic resonance (LSPR) which is the size 
dependence of the optical color allowing for size characterization.32, 35-36 This is an 
important phenomenon to ensure nanoparticles are of correct size. Metal nanoparticles 
also do not exhibit photo-blinking or photo-decomposition, which is crucial when 
monitoring cells for the long duration of time, since the intensity of nanoparticles will be 
constant. 36-37 
 
We previously studied Ag NPs with average diameters of 11.8 ± 2.6 nm and 97 ± 
13 nm to measure efflux kinetics in a gram-positive bacterium, B.subtilis using Ag NPs 
as probes.38-39 We also studied the efflux pump functions in P.aeruginosa (a gram-
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negative bacterium) using Ag NPs of an average diameter of 13.1 ± 2.5 nm and 91.0 ± 
9.3 nm. 40 
 
In this study, we synthesized, purified and characterized 12.3 ± 1.8 nm Ag NPs. 
LSPR of Ag NPs were used to determine the size of single NPs in real time. This was to 
determine if NPs are in the intracellular and extracellular region of MsbA cells. To inhibit 
the ABC pump we used orthovanadate, 28-29 an inhibitor for ABC pump in MsbA cells, to 
determine whether alternative efflux mechanisms of Ag NPs were present in these cells. 
Orthovanadate binds to NBD site and causes a conformation change and closes the 
TMD site. 26 
 
 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Stable Ag NPs (12.3 ± 1.8 nm) 
We have synthesized Ag NPs as described previously and in Methods.38, 41-42 Ag 
NPs were purified by rinsing/washing with nanopure water were centrifuged to remove 
any unreacted chemicals and chemical residues. Washing and centrifugation of NPs will 
increase the surface charge preventing them from aggregating NPs. The purified NPs in 
water are stable for months, as previously reported.40, 43-44 Size and shape of NPs were 
determined by high-resolution transmission electron microscopy (HR-TEM) (Fig. 6A) 
shows that most of the NPs are spherical in shape. Size distribution as show in Figure 
6B was found to be 12.3 ± 1.8 nm, ranging from 8.4 to 19.0 nm. Dark-field optical 
images as shown in Figure 6C; the majority of them are blue, green, and few are red 
NPs.  Their LSPRs are shown in Figure 6D: blue color NP having peak wavelength 
(λmax) with full-width half maximum (FWHM) at 469 (83.1) nm, green λmax 540 (101.3) 
nm, and red λmax at 605 (106.5) nm. 
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Figure 6: Characterization of the size, shape, and concentration of Ag NPs in 
Nanopure water.  
(A) HR-TEM images of Ag NPs show a spherical shape and average size distribution of 
12.3 ± 1.8 nm. (B) Histogram of size distribution of Ag NPs shows the average size of 
nanoparticles to be 12.3 ± 1.8 nm. (C) DFOM image of single Ag NPs in water showed 
majority blue. (D) LSPR spectra of single NPs as squared in (C) Blue, green and red 
with λmax at (i) 469 nm (ii) 540 nm (iii) 605 nm respectively (E) The color distribution of 
Ag NPs in water are (72 ± 2) % blue, (22 ± 2) % green and (6 ± 1) % red NPs. (F) 
Representative UV-vis absorbance spectra of 1.4 nM Ag NPs well dispersed in water 
peak wavelength is 393 nm and FWHM is 64.3 nm. Scale bars are 10 nm in (A) and 2 
µm in (C) (Scale bar in (C) shows the distance between single NPs, but not their sizes. 
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Figure 7: Characterization of optical properties and stability of Ag NPs in PBS. 
(A) Representative UV-vis absorbance spectra of 12.3 ± 1.8 nm Ag NPs well dispersed 
in medium at (a) 0 h and (b) 12 h. (B) The size distribution of Ag NPs of a 1.4 nM Ag 
NPs solution in PBS buffer as determined by DLS remained nearly a constant with an 
average value of (12.33 ± 2) nm. (C) The total number of nanoparticles/image of a 1.4 
nM Ag NPs solution in PBS buffer remained nearly a constant for the duration of the 
experiment (12 h) with an average value of ( 243 ± 5) NPs/20images.  
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To study the efflux function and accumulation rates, bacteria were suspended in 
phosphate buffer saline (PBS) buffer instead of the medium since bacteria cells will 
continue to grow in the medium. 6-7, 9, 30, 45 It is important to study the stability (non-
aggregated) of NPs in PBS buffer over the duration of the experiments. We studied the 
viability of MsbA in PBS buffer: bacteria cells were viable for at least 8 h at room 
temperature (data not shown). Figure 7A shows UV-vis spectra of Ag NPs solution at 
time zero and at 12 h of the experiment. The peak wavelength remained unchanged 
over time, indicating that the sizes and shapes of NPs remain unchanged; however, the 
absorbance is slightly decreased due to adsorption of PBS buffer on the NPs. The size 
distributions of NPs were then characterized by dynamic light scattering (DLS) which 
shows average diameter of NPs as shown in Figure 7B. The size of NPs was larger at 
12 h; this may be attributed to solvation of NPs with the buffer. The diameter of NPs 
measured from HRTEM (dry vacuum) and DLS are different due to the different way of 
calculation of NPs. We further confirmed the stability of single NPs under dark-field 
optical microscopy and spectroscopy (DFOMS) (Fig. 7C), the average number of NPs 
per 20 images was 243 ± 5. If there were aggregation of NPs, we would have seen 
fewer NPs as time proceed. From Figure 7 we can conclude Ag NPs are stable in buffer 
solution for at least 12 h.  
 
The representative dark-field optical images of the MsbA cells with single 
intracellular and extracellular NPs are shown in Figure 8A. Figure 8B consists of 
magnified images of intracellular NPs within the cells. Scattering Intensity of NP inside 
cells were low since the dark-field microscopy illuminator needs to pass through the cell 
membrane and reach detector hence, NPs look dimmer inside whereas extracellular 
has higher intensity and looks brighter as shown in Figure 8C. This distinguishing 
feature of the NPs enables us to determine the intracellular or extracellular location. 
LSPR of NPs was acquired to distinguish NPs and cell debris. Cell debris will not have 
LSPR, hence they look white. The representative LSPR spectra (color) of single Ag NP 
in Figure 8D show individual NPs with peak wavelengths (λmax) at 530 (blue), 550 
(green) and 555 (green) nm, respectively. 
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Concentration-Dependent and accumulation rate of Single NPs in Single Live 
Cells 
   We want to know whether MsbA with single NPs have the same attributes of 
pump substrates (eg, antibiotics) and exhibit concentration-dependence. 1.4 nM Ag 
NPs, at 10.5, 30.5, and 50.5 min, the accumulation of intracellular NPs was 16.7, 16.5 
and 14.0 intracellular NPs/min for 300 cells, respectively (Fig. 9Ab). For cells incubated 
with 0.7 nM Ag NPs, the accumulation of intracellular NPs was 10.9, 9.7, and 6.4 
NPs/min at 10.5, 30.5, and 50.5 min (Fig. 9Bb). From (Fig. 9Ab-9Bb), the number of 
intracellular NPs depends on NP concentration. When concentration of NPs is 
increased from 0.7 nM to 1.4 nM which is 2x increases in concentration we saw 2x 
increase in accumulation rate. From these results, we can conclude that cells incubated 
with Ag NPs extrude the NPs in a concentration-dependent manner. 
 
Next, we used orthovanadate an inhibitor of MsbA pump since we do not have a 
genetic mutant and we inhibited its function with orthovanadate. After cells were 
incubated with 1.4 nM Ag NPs and orthovanadate, at the beginning i.e., 10.5 min, the 
accumulation of intracellular NPs was 13.4 intracellular NPs/min for 300 cells. When we 
compared with 1.4 nm Ag NPs we found similar accumulation rates of intracellular NPs 
due to orthovanadate onset time to show its actions. In contrast, the accumulation of 
intracellular NPs was 32.4 and 53.9 intracellular NPs/ min at 30.5 and 50.5 min (Fig. 
9Aa), which was an increase in accumulation of NPs. The accumulation rate (slope of 
the plot) of 1.4 nM Ag NPs with orthovanadate is 1.08 NPs/min at 30.5, whereas for 1.4 
nM Ag NPs alone is 0.65, which was 1.7 times more than Ag NPs. The quantitative 
intracellular NPs accumulated and the accumulation rate in single live cells at a given 
times are summarized in Table 1. As previously mentioned, we also studied the 0.7 nM 
Ag NPs where the number of intracellular NPs 10.9 , 9.7 and 6.4 min at 10.5, 30.5 and 
at 50.5 min (Fig. 9Bb), whereas cells incubated with orthovanadate and 0.7 nM Ag NPs 
showed 8.9, 10.4 and 22.6 at 10.5 , 30.5 and 50.5 min (Fig. 9Ba).  
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Figure 8: Imaging of single intracellular and extracellular 12.3 ± 1.8 nm Ag NPs in 
single living bacterial cells using DFOMS.  
(A) The representative optical image of bacterial cells incubated with 1.4 nM Ag NPs 
showing extracellular NPs as squared. (B, C) Zoom in optical color images of single 
cells shows (B) intracellular and (C) extracellular NPs. The scale bar in A and B are 5 
and 2 µm, respectively. (D) LSPR spectra of Single 12.3 ± 1.8 nm Ag NPs show peak 
wavelength at 530 nm, 550 and 555 nm. 
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Figure 9: Study of efflux kinetics of MsbA membrane transporter using 12.3 ± 1.8 
nm Ag NPs.  
 
(A) Plots of number of intracellular Ag NPs in MsbA incubated with (a) 1.4 nM Ag NPs 
with Orthovanadate and (b) 1.4 nM Ag NPs (B) Plots of number of intracellular Ag NPs 
in MsbA incubated with (a) 0.7 nM Ag NPs with Orthovanadate and (b) 0.7 nM Ag NPs. 
(C) Plots of fluorescence intensity of EtBr dye at (a) 15.0 µM with Orthovanadate (b) 
and 15.0 µM versus time. 
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We further studied the time course of fluorescence intensity of 15 µM ethidium 
bromide (EtBr) in the cell solution with and without orthovanadate in order to study the 
accumulation rate. More EtBr is accumulated in cells with orthovanadate (Fig. 9Ca) until 
60 min; after that, the accumulated rate decreased whereas EtBr and cells remained 
almost same (Fig. 9Cb). From Figure 9Aa, 9Bb and 9Ca after 60 min orthovanadate did 
not work which indicated that cells used all orthovanadate available in the solution. 
 
 
 
 
Table 1: Study of Accumulation Rates and Number of Intracellular Single 12.0 nm NPs 
in Single Live Cells 
 
Diameter 
(nm) a 
C Ag NPs 
(nM) 
Accumulation 
Rate (NPs min-1)b 
Number of 
Intracellular NPsc 
12.3 ± 1.8 
1.4 nM + orthovanadate 1.08 46 
1.4 nM  0.65 33 
0.7 nM + orthovanadate 0.39 19 
0.7 nM  0.39 21 
 
a Diameter of NPs measured by TEM; 
b Accumulation rates (slopes of plots) of the NPs in 300 live cells over 30.5 min (Figure 
9 ); 
c Number of intracellular NPs accumulated in 300 live cells at 30.5 min incubation; 
 
 
 
 
From these results, we can conclude that cells incubated with Ag NPs extrude the NPs, 
whereas cell incubated with orthovanadate and Ag NPs do not extrude the  NPs, 
causing more persistent accumulation of NPs. In this study the size of NPs were much 
smaller than regular antibiotics which are effluxed out from MsbA pump. NPs cannot be 
engulfed (pinocytosis, endocytosis, and exocytosis) inside the bacteria cells because 
they do not have this capability.  
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Viability of Single Cells 
The viability of single cells with NPs is a key step in the study of accumulation of 
intracellular NPs since NPs easily enter into dead cells. The cells and NPs incubated 
with and without orthovanadate were characterized by live/dead BacLight viability and 
counting assay.46 This assay used SYTO9, a green fluorescent nucleic acid stain and 
propidium iodine, a red fluorescence nucleic acid stain to distinguish live and dead cells 
respectively. SYTO9 labels those bacteria with the intact or live cells but not dead cells 
whereas propidium iodine penetrates only into damaged cell membranes leading to a 
reduction of SYTO9 fluorescence intensity. Bacteria with intact cell membrane (alive 
cells) penetrate SYTO9 and appear to the green fluorescence (λmax at 520 nm) whereas 
damaged (dead cells) penetrate propidium iodine and appear to the red fluorescence 
(λmax at 610 nm), which enabled us to distinguish between live and dead cells.  
 
Representative optical images of the MsbA cells incubated with 1.4 nM Ag NPs 
with orthovanadate (Fig. 10A) for a 2 h showed the cells with and without NPs; their 
fluorescent images are green (Fig. 10B), but not red fluorescent. We can conclude that 
cells are alive with and without NPs. We calculated the number of live cells and dead 
cells and showed the percentage of the cells by dividing the number of live cells over 
the total number of cells. The results showed that 98 % (Fig. 10Ca) and 95 % (Fig. 
10Cb) were live for at least 2 h when incubated with 1.4 nM Ag NPs with and without 
orthovanadate respectively. Cells incubated with 0.7 nm Ag NPs with and without 
orthovanadate were live with 99 % (Fig. 10Cc) and 95 % live (Fig. 10Cd), respectively. 
This result shows that the accumulation of NPs is not by cell membrane damage. 
 
SUMMARY  
In summary, we have successfully synthesized 12.3 ± 1.8 nm Ag NPs. We used 
localized surface plasma resonance of Ag NPs to determine the size and also to 
determine whether NPs are localized intracellular or extracellular with respect to the 
bacterial cell membrane. 1.4 nM Ag NPs are stable in PBS buffer for at least 12 h. We 
observed a concentration-dependent efflux function when incubated with 1.4 nM and  
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Figure 10: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay.  
Representative dark-field optical image (A) and fluorescence image (B) of single 
bacterial cells (MsbA), incubated with 1.4 nM Ag NPs with Orthovanadate over the 
duration of each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of 
SYTO9, indicating that cells are viable. (C) Plots of percentage of viable cells (a) 1.4 nM 
Ag NPs and orthovanadate (b) 1.4 nM Ag NPs cells (C) 0.7 nM Ag NPs and 
orthovanadate (d) 0.7 nM Ag NPs of MsbA, indicate that 95-99% of the cells are alive. 
Minimum 300 cells were assayed and analyzed. The scale bar is 2 µm. 
B A B 
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0.7 nM Ag NPs. We incubated cells with Ag NPs and orthovanadate, an inhibitor of ABC 
transporters, after the onset of time of orthovanadate; we saw more of intracellular NPs. 
Accumulation rate was 1.7 times more when incubated with orthovanadate. Inhibition of 
pump with orthovanadate causes accumulation of a higher number of intracellular NPs. 
More than 95% of cells are viable for 2 h incubated with Ag NPs which indicating that 
NPs are biocompatible and can be used to study efflux functions. From this study, we 
can conclude that Ag NPs can be used as probes that enter into the cell passively and 
efflux out through ABC transporter.  
 
METHODS 
Reagents and cell line 
Silver perchlorate monohydrate (99%) was purchased from Alfa Aesar. Sodium 
citrate (99%), sodium borohydride (NaBH4) (98%), sodium orthovanadate (99%) 
Ethidium bromide, sodium chloride, sodium phosphate, sodium phosphate monobasic 
monohydrate, bacto-tryptone and bacto yeast extract were purchased from Sigma-
Aldrich. Live/dead BacLight viability and counting assay was purchased from Invitrogen. 
All reagents were used as received. The nanopure deionized (DI) water (18 MΩ water, 
Barnstead) was used to prepare all solutions including 50 mM phosphate buffer saline 
(PBS) (pH=7.2, 0.5 mM phosphate buffer and 1.5 mM sodium chloride) and rinse 
glassware. MsbA (Escherichia coli, wt w3110) cells were purchased from purchased 
from Coli Genetic Stock Center (CGSC).  
 
Synthesis and characterization of Ag NP optical probes 
Ag NPs (12.3 ± 1.8 nm) were synthesized and purified as described previously.38, 
41, 47 Sodium borohydride (10 mM) solution was mixed with ice-cold sodium citrate (3 
mM). Silver perchlorate (10 mM, ice-cold) was rapidly added to the mixture and the 
solution was homogeneously stirring at room temperature overnight. The solution was 
filtered through 0.22 µm membrane and washed twice with nanopure water using 
centrifugation (Beckman Optima L90k) at 15,000 rcf (relative centrifugal force). The 
purified Ag NPs were resuspended in nanopure water and stored in dark at 4°C. The 
molar concentration of Ag NPs was determined and calculated using UV-vis 
21 
 
 
 
spectroscopy (Hitachi U-2010) as described previously. The washed Ag NPs were 
determined their sizes using high-resolution transmission electron microscopy (HRTEM, 
FEI Tecnai G2 F30 FEG) and dynamic light scattering (DLS, Nicomp 380ZLS particle 
size system). Optical properties of NPs were characterized using dark-field optical 
microscopy and spectroscopy (DFOMS).Our setup for DFOMS is explained in our 
previous studies.32, 35-38, 40, 42-44, 48-49 Our DFOMS is equipped with a dark-field optical 
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× 
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth 
of field (focus) of 190 nm, a charge coupled device (CCD) camera (Micromax, Roper 
Scientific) and Multispectral Imaging System (Nuance, CRI). 37 ,50 
 
The purified Ag NPs suspended in nanopure water and 0.5 mM PBS was 
characterized over 12 h to investigate their stability (non-aggregated) using UV-vis 
spectroscopy and dynamic light scattering. Ag NPs dispersed in 0.5 mM were sampled 
to take dark-field optical images (initial, 4h, 8h and 12h). The experiment was done in 
triplicate and total number of NPs of each run was counted at all-time points.  
 
Cell culture and preparation 
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of 
luria broth (LB) medium (1% tryptone peptone, 0.5% yeast extract and 0.5% sodium 
chloride, pH = 7.2) in a shaker (Lab-line Orbit Envivon-Shaker) (150 rpm, 37°C) for 12h. 
The cells were further cultured in the LB medium for another 8 h. We harvested the 
cultured cells using centrifugation (Beckman Model J2-21 Centrifuge, JA-14 rotor) at 
1500 rpm for 10 min. The cells were washed with the PBS three times and resuspended 
in the PBS. The final concentration of the cells was adjusted to OD600nm = 0.1 and used 
for the entire experiments. 
 
Imaging of single intracellular and extracellular Ag NPs in single living cells 
The cell suspensions (1 mL) containing 0.7 nM and 1.4 nM of Ag NPs in the 
presence and absence of orthovanadate (25 µM) were prepared. The incubation time 
was started after adding Ag NPs to the cell suspension. The suspension was sampled 
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(1 µL) in every 20 min and prepared the micro-chamber slide. The cells were imaged at 
representative locations in every minute using DFOMS equipped with a CCD camera.  
 
At the end of each experiment, the viable cells were characterized using 
live/dead BacLight bacterial viability and counting assay.46 The cells were imaged dark-
field optical microscopy and epi-fluorescence microscopy for at least 300 cells. The 
green fluorescent cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 
nm) were counted as viable cells and the red fluorescent cells (peak wavelength of 
fluorescence spectra of propidium iodide, λmax = 610 nm) were counted as dead cells. 
 
Fluorescence spectroscopy measurements 
Time-dependent of fluorescence intensity of 15 µM ethidium bromide incubated 
with the 3 mL cells in the presence and the absence of orthovanadate was measured in 
a 3 s interval using a fluorescence spectrometer (Perkin-Elmer LS50B). The excitation 
and emission wavelengths were 488 and 590 nm, respectively. 
 
Data analysis and statistics 
For characterization of NPs size and color distribution, we measured at least 100 
NPs by using HR-TEM and DFOMS for each measurement and each measurement 
was repeated three times. Therefore, a minimal of 300 NPs was characterized giving 
sufficient statistics for determination of size distribution.  
 
We acquired 20 representative images of each cell suspensions incubated with 
1.4 nM, 0.7 nM Ag NPs with and without orthovanadate for every 20 min over a period 
of 2 h to study accumulation rate of intracellular NPs in single cells. Therefore nearly 
~100 cells were imaged every 20 min, and 600 cells were studied over 2 h for each 
measurement. Each experiment was repeated three times. Thus, 1800 cells were 
studied for each sample, which allowed us to gain sufficient statistics for probing 
accumulation rates and efflux kinetics of bulk cells at single cell resolution. 
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CHAPTER III 
STUDY OF SIZE-DEPENDENCE OF INHIBITORY EFFECTS OF DRUG NANO-
CARRIERS IN BACILLUS SUBTILIS 
 
INTRODUCTION: 
Multidrug resistance (MDR) is the leading cause of failure when treating cancers 
and bacterial infections.5 Bacteria acquire resistance to drugs by changes in the activity 
of MDR transporters, which extrude drugs or other substances outside the cells.5 Two 
types of MDR transporters are present, proton gradient and adenosine triphosphate 
(ATP) binding cassette (ABC) transporter which use the energy of ATP hydrolysis to 
establish the gradient.1 ABC transporters are involved in the transport of a variety of 
structurally dissimilar compounds and contain two transmembrane domains (TMDs) and 
two nucleotide-binding domains (NMDs).1, 3-5 Studies have shown that the substrates 
bind to TMDs and form a way for substrates to cross the membranes, whereas NBDs 
bind and hydrolyze ATP to power the transporters, which causes the extrusion of 
substrates out of cells against the concentration gradient across the cellular 
membranes.1, 4-5  
 
Fluoroquinolones such as benofloxacin, danofloxacin, enrofloxacin, norfloxacin, 
and ofloxacin are widely used broad spectrum antibiotics51 used for the treatment of 
bacterial diseases such as pneumonia, chronic bronchitis, urinary tract infections and 
tuberculosis.52 To study antibiotic resistance levels in bacteria many qualitative and 
quantitative methods have been developed.53 Broth dilution and an agar plate technique 
are the most common method to study susceptibility of bacteria and determine the 
minimum inhibitory concentration (MIC) of antibiotics. 53 
 
Nanoparticles have gained much attention due to their wide applications.54-58 
Noble metal nanoparticles such as Gold (Au) and Silver (Ag) have distinctive optical 
properties, depending on size, charge, and the surrounding environment. 54-58 Ag NPs 
have high Rayleigh scattering and can be imaged under dark-field optical microscopy 
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using halogen as a source of illumination.32, 35, 37, 39-40, 43-44, 49-50, 59 The scattering 
intensity of nanoparticles is constant for long durations of time (eg, hours), which is 
crucial for monitoring cells over time. Additionally nanoparticles do not exhibit photo-
blinking or photo-decomposition. 32, 35, 37, 39-40, 43-44, 49-50, 59 Nanoparticle surfaces are 
functionalized with a receptor or mono-clonal antibody to identify a certain type of cells 
and are functionalized with drugs for drug delivery.59 Our group has developed a wide 
range of colors of single-molecule nanoparticle optical probes and biosensors 
(SMNOBS) that are utilized for the imaging and characterization of molecular 
mechanisms in single live cells.  
 
In our previous studies, we used aztreonam (AZT) which inhibits bacterial growth 
by destroying cell wall synthesis and we used chloramphenicol (antibiotic) to study 
efflux function in P.aeruginosa.34, 36 The size-dependent inhibitory effect of antibiotic 
drug nano-carriers in P.aeruginosa was also studied.60 In this study, we used three 
different sized drug nano-carriers and studied minimum inhibitory concentrations in 
B.subtilis. B.subtilis is a gram-positive bacteria which served as our model organism 
while studying efflux function of multidrug ABC membrane transporter. In addition, 78 
ABC transporters have been identified in B.subtilis species making it ideal for our 
studies.61-63  
 
RESULTS AND DISCUSSION: 
Synthesis and Characterization of Drug Nano-carriers  
We synthesized 2.4 ± 0.7 nm Ag NPs, 13.0 ± 3.1 nm Ag NPs, and 92.6 ± 4.4 nm 
Ag NPs as described in the earlier paper and in methods.35, 37, 40 Figure 11 shows 
representative images of TEM. Size distribution of the NPs were shown to be 2.4 ± 0.7 
nm, 13.0 ± 3.1 nm, and 92.6 ± 4.4 nm Ag NPs as described in the paper.60 Once NPs 
were synthesized and purified, NPs surface was functionalized with a monolayer of 11-
amino-1-undecanethiol hydrochloride (MUNH2). Once the reaction was completed we 
washed them and characterized AgMUNH2 NPs. The amine group of AgMUNH2 NPs 
was linked with Ofloxacin (Oflx) via a peptide bond with the carboxyl group of Oflx and 
amine group of MUNH2. Figure 12A schematic synthesis of 2.4 ± 0.7 nm AgMUNH-Oflx  
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Figure 11: Characterization of three different size Ag NPs using HRTEM. 
 
(A) Size characterization of 2.4 ± 0.7 nm Ag NPs. HRTEM image shows nearly uniform 
spherical nanoparticles. The scale bar is 5 nm. (B) Size characterization of 13.0 ± 3.1 
nm Ag NPs. HRTEM image shows nearly uniform spherical nanoparticles. The scale 
bar is 10 nm.(C) Size characterization of 92.6 ± 4.4 nm Ag NPs HRTEM image shows 
nearly uniform spherical nanoparticles. The scale bar is 100 nm. 
A 
C 
B 
26 
 
 
 
 
 
 
Figure 12: Illustration of synthesis of drug nano-carriers. 
 
Schematic illustration of functionalization of monolayer of 11-amino-1-undecanethiol on 
the surface of the NPs with diameters of (A) 2.4 ± 0.7, (B) 13.0 ± 3.1 and (C) 92.6 ± 4.4 
nm using the interaction of their thiol groups (-SH) with the surface of Ag NPs to prepare 
AgMUNH2 NPs and conjugation of the amine group of 11-amino-1-undecanethiol with 
the carboxyl group of the Oflx via peptide bonds using EDC and sulfo-NHS as 
mediators to prepare AgMUNH-Oflx NPs. 
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(drug nano-carriers), Figure 12B schematic synthesis of 13.0 ± 3.1 nm AgMUNH-Oflx 
NPs (drug nano-carriers) and Figure 12C schematic of the synthesis of 92.6 ± 4.4 nm 
AgMUNH-Oflx NPs (drug nano-carriers).  
 
 Dark-field optical images of 2.4 ± 0.7 nm Ag NPs (Fig. 13Aa), AgMUNH2 (Fig. 
13Ab), and AgMUNH-Oflx NPs (Fig. 13Ac) showed majority blue color NPs in Ag NPs, 
green color in AgMUNH2 and green color in AgMUNH-Oflx NPs. LSPR Figure 13Ad of 
Ag NPs, NPs functionalized with MUNH2 and Oflx, NPs shift from blue to green and 
peak wavelength (λmax) 482, 534, and 555 nm.  Dark-field optical images of 13.0 ± 3.1 
nm Ag NPs (Fig. 13Ba), AgMUNH2 (Fig. 13Bb), and AgMUNH-Oflx NPs (Fig. 13Bc), 
showed majority blue, green and few red color NPs in Ag NPs, green color in AgMUNH2 
and green color in AgMUNH-Oflx NPs. LSPR (Fig. 13Bd) of Ag NPs, NPs functionalized 
with MUNH2 and Oflx, peak wavelength (λmax) of NPs are 521, 535, and 554 nm.  Dark-
field optical images of 92.6 ± 4.4 nm Ag NPs (Fig. 13Ca), AgMUNH2 (Fig. 13Cb), and 
AgMUNH-Oflx NPs (Fig. 13Cc) showed majority green and few red color NPs in Ag 
NPs, green color in AgMUNH2 and green color in AgMUNH-Oflx NPs. LSPR of Ag NPs 
are functionalized with MUNH2 and Oflx, peak wavelength (λmax) of NPs are 533, 560, 
and 580 nm. The shift of NPs is due to decrease of the surface refractivity and dielectric 
constant as well as increasing in sizes.  
 
We studied the stability of antibiotic drug nano-carriers in the medium as shown 
in the previous paper.60 We determined the conjugation ratio (the number of Oflx 
molecules attached to a single NP) of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as 
8.6x102, 9.4x103, and 6.5x105 respectively. 
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Figure 13: Characterization of plasmonic optical properties of single (a) Ag NPs, 
(b) AgMUNH2 NPs, (c) AgMUNH-Oflx NPs and (d) LSPR of individual NPs. 
 
(A)  Dark-field optical image of single 2.4 ± 0.7 nm Ag NPs (i) blue color Ag NPs, (ii) 
green color AgMUNH2 NPs (iii) green color AgMUNH-Oflx NPs (d) Normalized 
scattering intensity of single NPs in (A) shows with peak wavelength (λmax) and full-
width-half maximum (FWHM) at (i) 482 (50) (ii) 534 (113) and (iii) 555 (120) nm. (B)  
Dark-field optical image of single 13.0 ± 3.1 nm Ag NPs, (i) green color Ag NPs (ii) 
green color AgMUNH2 NPs (iii) green color AgMUNH-Oflx NPs (d) Normalized 
scattering intensity of NPs in (B) shows with λmax (FWHM) at (i) 521 (47) and (ii) 535 (67) 
and (iii) 554 (81) nm. (C)  Dark-field optical image of single 92.6 ± 4.4 nm Ag NPs (i) 
green color Ag NPs, (ii) green color AgMUNH2 NPs and (iii) green color AgMUNH-Oflx 
NPs (d) Normalized scattering intensity of NPs in (C) shows with λmax (FWHM) at (i) 533 
(99) (ii) 560 (121) and (iii) 580 (147) nm. The scale bars are 10 µm showing distance 
among individual NPs but not their sizes due to the optical diffraction limit. 
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Cell function in modified medium  
Since antibiotic drug nano-carriers are aggregated in the standard medium, the 
medium was modified medium in such a way that the drug nano-carriers were stable in 
medium (we call this modified medium). It is very important to make sure cell function is 
the same in modified medium hence we studied the growth curve and efflux functions of 
B.subtilis cells in modified medium and regular medium. We followed the growth curve 
of two strains of B.subtilis: WT normal expression of BmrA (Bacillus multidrug 
resistance ATP) and ΔBmrA deleted BmrA pump in standard and modified medium. 
Results, as shown in Figure 14Aa (standard medium) and Figure 14Ab (modified 
medium) of WT demonstrate that the growth curves are almost the same. The same 
phenomenon was seen for ΔBmrA in Figure 14Ba and Figure14Bb in regular and 
modified medium respectively. At the end of the growth period, i.e. 18 h, cell viability 
was measured by using live/dead BacLight assay. Live/dead BacLight assay contain 
two fluorescent dyes: green fluorescent dye SYTO9 (λmax = 520 nm) which binds nucleic 
acids which stains only live cells thus live cells appear green fluorescent and a red 
fluorescent dye propidium iodide (λmax = 610 nm) which penetrates into damaged or 
disintegrated cells showing in red fluorescence.46 Figure 15 shows representative 
optical images (Fig. 15A) and green fluorescence (Fig. 15B) of WT in Figure 15Aa, 
Figure 15Ab cells in standard medium and modified medium respectively. We counted 
the number of live and dead cells and calculated the percentage of viable cells by 
dividing the number of live cells over the total number of the cells. The results show that 
97-100% of the cells are viable for both strains and in both mediums (Fig. 15C). From 
these results, we can conclude that cells are growing normally in modified medium also. 
We next studied the effluxed mechanism using Hoechst dyes. Cells were incubated with 
2 µM Hoechst dye and we studied the time course of fluorescence intensity for the 
duration of 40 mins for both the strains, in both the standard medium and modified 
medium. Figure 16A is the time course of fluorescence intensity in the standard 
medium, whereas Figure 16B is in the modified medium time course. From 0-15 mins, a 
higher amount of Hoechst dye accumulated in ΔBmrA (Fig. 16Ab). After 15 mins, cells 
reached saturation and remained constant for 40 mins, whereas in WT (Fig. 16Ca) it 
remained constant over time.  
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Figure 14: Characterization of growth curves of the cells cultured in (a) standard 
and (b) modified LB medium.  
  
The cellular growth curves of: (A) WT, (B) ΔBmrA cultured in (a) standard and (b) 
modified LB medium over time shows that the growth rates of a given strain in either 
medium are nearly identical, which indicates that the modified LB medium is well suited 
to culture the cells.  
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Figure 15: Viability of the cells (WT, ΔBmrA) cultured in (a) standard and (b) 
modified LB medium using Live/Dead BacLight assay.  
 
(A) Optical and (B) fluorescence images of the cells (e.g., WT), that were cultured over 
12 h, and suspended in the PBS buffer and assayed using Live/Dead BacLight assay. 
The cells exhibiting green fluorescence and red fluorescence are counted as live and 
dead cells, respectively. (C) Plot of the percent of the live cells (live cells divided by the 
total number of given cells) cultured in (a) standard and (b) modified LB medium show 
that more than 97% of the cells (WT, ΔBmrA) are viable, which further indicates that the 
modified LB medium is well suitable to culture the cells. The scale bars in (A-B) are 5 
µm. 
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Figure 16: Characterization of accumulation and efflux kinetics of the Hoechst 
dye for live cells cultured in (A) standard and (B) modified LB medium.  
 
Time-dependent fluorescence intensity of Hoechst (2 µM) incubated with the cells 
(OD600 nm = 0.1 in PBS buffer, pH 7.2): (a) WT and (b) ΔBmrA cultured in (A) standard 
and (B) modified LB medium exhibit almost same accumulation and efflux kinetics, 
demonstrates that the modified LB medium is well suitable to culture the cells for the 
study of accumulation and efflux kinetics of B.subtilis 
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Even 16B showed the same phenomena indicating that cells are effluxing 
Hoechst dye as usual in the modified medium as well. From this we can conclude that 
cell function is the same in modified medium. 
 
Study of size-dependent biocompatibility and toxicity of the drug nano-carriers 
We incubated B.subtilis (WT and ΔBmrA) with different concentration of 2.4 ± 0.7 
nm AgMUNH-Oflx, 13.0 ± 3.1 nm AgMUNH-Oflx, 92.6 ± 4.4 nm AgMUNH-Oflx, and Oflx 
alone. For controls NPs, the highest concentration of 2.4 ± 0.7 nm AgMUNH2, 13.0 ± 3.1 
nm AgMUNH2, and 92.6 ± 4.4 nm AgMUNH2 were used. Figure 17 shows test tubes 
images taken at 18 h of incubation with samples. Figure 17A, 17C, 17E, and 17D are 
WT cells and Figure 17B, 17D, 17F, and 17H are ΔBmrA cells. Figure 17A and 17B 
were 2.4 ± 0.7 nm drug nano-carriers, Figure 17C and 17D were 13.0 ± 3.1 nm drug 
nano-carriers, and Figure 17E and 17F was 92.6 ± 4.4 nm drug nano-carriers with 
different concentration of Oflx. The concentration of drug nano-carriers is converted to 
Oflx concentrations based on the conjugation ratio, 0.06, 0.11, 0.22, 0.42, and 0.72 µM 
from a-e, whereas f was 0.72 µM of 2.4 nm AgMUNH2, as concentration of Oflx 
increased, the bacteria growth decreased whereas samples contain AgMUNH2 with the 
highest concentration (0.72 µM) did not inhibit growth of bacteria indicating that 
AgMUNH2 is biocompatible to cells. Figure 17G, 17H is Oflx alone as the concentration 
of oflx increased from 0.00, 0.06, 0.11, 0.22, 0.42, and 0.72 µM from a-f bacterial growth 
was inhibited.  
 
Beyond qualitatively looking visually or at the turbidity of the test tube, we further 
quantified the growth by measuring the absorbance (optical density) at 600 nm 
(OD600nm) which is one standard method used to measure bacteria growth. We plotted a 
graph of OD600nm versus concentration in µM as shown in Figure 18A as WT Figure 18B 
as ΔBmrA a, b, c is 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm AgMUNH2 NPs d, e, f, g are 
2.4 ± 0.7 nm AgMUNH-Oflx, Oflx, 13.0 ± 3.1 AgMUNH-Oflx, and 92.6 ± 4.4 nm 
AgMUNH-Oflx. 
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Figure 17: Determination of minimum inhibitory concentrations (MIC) of 
AgMUNH2-Oflx NPs and ofloxacin in B.subtilis.  
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Figure 17 cont.: A, C, E and G in WT B.subtilis (WT) while B, D, F and H in Δ B.subtilis 
( ΔBmrA) at 18 h. (A, B) Images of test tubes of cells containing conjugated ofloxacin in 
2.4 ± 0.7 nm AgMUNH-Oflx at (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42, and (e) 0.72 µM. 
Cells also were incubated with AgMUNH2 NPs (drug free) at 0.72 µM (f). (C, D)Images 
of test tubes of cells containing conjugated Ofloxacin in 13.0 ± 3.1 nm AgMUNH-Oflx at 
(a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42, and (e) 0.72 µM. Cells also were incubated with 
AgMUNH2 NPs (drug free) at 0.72 µM (f). (E, F) Images of test tubes of cells containing 
conjugated ofloxacin in 92.6 ± 4.4 nm AgMUNH-Oflx at (a) 0.06, (b) 0.11, (c) 0.22, (d) 
0.42, and (e) 0.72 µM. Cells also were incubated with AgMUNH2 NPs (drug free) at 0.72 
µM (f). (G, H). Images of test tubes of cells containing Oflx at (a) 0.0, (b) 0.06, (c) 0.11, 
(d) 0.22, (e) 0.42, and (f) 0.72 µM after 18 h incubation. 
 
 
 
From Figure 18, as the concentration of Oflx increased the absorbance 
decreased indicating that bacteria growth is dependent on concentration of Oflx. The 
order of the growth curve was 2.4 ± 0.7 nm AgMUNH-Oflx NPs growth was more than 
Oflx alone. Next was 13.0 ± 3.1 nm AgMUNH-Oflx NPs and was 92.6 ± 4.4 nm 
AgMUNH-Oflx NPs. AgMUNH2 NPs are almost same as 0.0 µM of Oflx indicating that 
AgMUNH2 is biocompatible. We calculated 50% of the minimum inhibitory concentration 
using an exponential decay curve fitting y=a*exp(b*x),64 found MIC50 values (Table 2) 
were 0.401 ± 0.021, 0.162 ± 0.002, 0.118 ± 0.006, and 0.013 ± 0.006 µM for WT 
whereas for ΔBmrA 0.490 ± 0.027, 0.174 ± 0.017, 0.111 ± 0.011, and 0.013 ± 0.001 µM 
for 2.4 ± 0.7 nm AgMUNH-Oflx, Oflx alone, 13.0 ± 3.1 nm AgMUNH-Oflx, and 92.6 ± 
4.4nm AgMUNH-Oflx respectively. We saw a size dependent inhibitory effect in both 
strains. No strain dependency was observed, possibly because the concentration was 
too high or low, or cells had already acquired resistance.  
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Figure 18: Plot of absorbance (y) versus the concentration, MIC50 is calculated 
from using exponential decay with y=a exp(-bx) equation at 18 h. 
 
A and B MIC of Oflx in WT and ΔBmrA using UV-vis spectroscopy. (a) 2.4 ± 0.7 nm 
AgMUNH2 (b) 13.0 ± 3.1 nm AgMUNH2 (c) 92.6 ± 4.4 nm AgMUNH2 (d) 2.4 ± 0.7 nm 
AgMUNH-Oflx y WT= 0.170e
(-1.961c) ,R2 = 0.841 ; y ΔBmrA = 0.189e
(-1.586 c), R2 = 0.711, (e) 
Oflx alone y WT =0.174e
(-4.996c), R2 = 0.918 ; y ΔBmrA = 0.193e
(-4.542c), R2 = 0.924 ,(f) 13.0 ± 
3.1 nm AgMUNH-Oflx y WT =0.169e
(-6.591c), R2 = 0.886 ; y ΔBmrA = 0.183e
(-7.025c), R2 = 
0.907 and (g) 92.6 ± 4.4 nm AgMUNH-Oflx y ΔBmrA = 0.155e
(-53.330c), R2 = 1.00 ; y ΔBmrA = 
0.172e(-52.860 c), R2 = 1.00. 
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UV-vis absorbance is a bulk phenomenon and from the absorbance data, it is 
unknown how the morphology of the bacterium changed due to the inhibitory effects of 
Oflx. The inhibitory effect is due to the accumulation of NPs. To circumvent these 
limitations, we used DFOMS images to observe the bacterial morphology as well as to 
count the number of bacteria for each concentration. As shown in Figure 19, there are 
dark-field images of a bacteria cell with drug nano-carriers. We saw few NPs attached 
to cells. Figure 19a, 19b, 19c, and 19d are 2.4 ± 0.7 nm, 13.0 ± 3.1 nm , 92.6 ± 4.4 nm 
AgMUNH-Oflx NPs and cells alone respectively. In the cells in Figure 19a, 19b, and 19c 
some cells have not divided properly indicating Oflx inhibited cell division; the 
mechanism action of Oflx is by DNA gyrase and DNA gyrase is required to complete 
replication prior to cell division.51 
 
 
 
 
Table 2: Summary of Minimum Inhibitory Concentration AgMUNH2-Oflx for B.subtilis 
 
NPs 
Ag NPs  WT ∆ BmrA 
Diameter 
(nm) 
UV-vis 
Single 
Cells 
UV-vis 
Single 
Cells 
2 nm AgMUNH-Oflx 2.4 ±0.7 0.401 0.165 0.494 0.189 
13 nm AgMUNH-Oflx 13.0 ±3.1 0.118 0.078 0.107 0.040 
92 nm AgMUNH-Oflx 92.6 ±4.4 0.013 0.013 0.013 0.015 
Ofloxacin n/a 0.162 0.124 0.177 0.065 
 
 
* MIC calculated at 50% at T 18 h.  
 
 MIC is calculated from y= a exp(-bx) 
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Figure 19: Representative images of MIC experiment of single intracellular and 
extracellular of drug nano-carriers. 
 
 AgMUNH-Oflx NPs incubated with  0.06 µM for a, b, and c and 0.0 µM  d respectively, 
in WT strain at 18 h. (a) 2.4 ± 0.7 nm AgMUNH-Oflx NPs and (b) 13.0 ± 3.1 nm 
AgMUNH-Oflx NPs (c) 92.6 ± 4.4 nm AgMUNH-Oflx NPs and (d) cells alone. The scale 
bar is 2 μm in all images.  
 
d 
a 
c 
b 
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In Figure 20 are representative images of DFOMS of Figure 20A, 20B, 20C, and 
20D was WT cells are 2.4 ± 0.7 nm, 13.0 ± 3.1 nm, 92.6 ± 4.4 nm AgMUNH-Oflx NPs 
and Oflx respectively with different concentrations of Oflx. Concentration of AgMUNH-
Oflx NPs (drug nano-carriers) were converted to Oflx concentrations based on the 
conjugation ratio, 0.06, 0.11, 0.22, 0.42, and 0.72 µM from a-e, whereas f is 0.72 µM of 
AgMUNH2 in Figure 20A, 20B, 20C, and 0.0 µM of Oflx in Figure 20D. As the 
concentration of Oflx increased we saw less number of bacteria with 2.4 ± 0.7 nm 
AgMUNH-Oflx NPs. Figure 20A bacteria cell growth is only three concentrations 0.06, 
0.11, 0.22 µM, for 13.0 ± 3.1 nm AgMUNH-Oflx NPs as shown in Figure 20B bacteria 
growth only in 0.06 and 0.11 µM, for 92.6 ± 4.4 nm AgMUNH-Oflx NPs as shown in 
Figure 20C bacteria growth only in 0.06 µM for Oflx as shown in Figure 20D bacteria 
growth in 0.06, 0.11, 0.22 µM concentrations. In contrast to these, AgMUNH2 NPs grew 
almost the same as 0.0 µM of Oflx. The concentration of AgMUNH2 was 0.72 µM, the 
highest concentration we used for the treatment of bacteria cells. In Figure 20 Af, 20 Bf, 
20 Cf cells grew to the same extent as 0.0 µM of Oflx, indicating that AgMUNH2 NPs are 
biocompatible. From this, we can conclude that Ag NPs toxic effects are lowered by 
functionalizing with the MUNH2 group. This is important for application of Ag NPs in the 
diagnosis and for making NPs biocompatible to reduce toxicity.  
 
We further counted the number of bacteria for each concentration as shown in 
Figure 21A as WT, Figure 21B as ΔBmrA a, b, c with 2.4 ± 0.7, 13.0 ± 3.1 and 92.6 ± 
4.4 nm AgMUNH2 NPs. Whereas d, e, f, g are 2.4 ± 0.7 nm AgMUNH-Oflx NPs, Oflx, 
13.0 ± 3.1 nm AgMUNH-Oflx and 92.6 ± 4.4 nm AgMUNH-Oflx NPs, used cumulative of 
three runs.65 The same phenomenon was seen in Figure 18 and calculated MIC50 
values (Table 2) were 0.165, 0.126, 0.078, and 0.013 µM for WT, whereas for ΔBmrA 
0.189, 0.065, 0.040, and 0.015 µM for 2.4 ± 0.7 nm AgMUNH-Oflx, Oflx alone 13.0 ± 3.1 
nm AgMUNH-Oflx and 92.6 ± 4.4 nm AgMUNH-Oflx respectively.  
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Figure 20: Representative images of WT cells after 18 h incubation showed dose 
and size dependent antimicrobial activities.  
 
The cells incubated with (A) 2.4 ± 0.7; (B) 13.0 ± 3.1; (C) 92.6 ± 4.4 nm AgMUNH2-Oflx 
at concentration (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42 and (e) 0.72 µM indicated that as 
drug concentrations increased, number of cells decreased . Differently, the cells 
incubated with (A f) 2.4 ± 0.7; (B f) 13.0 ± 3.1; (C f) 92.6 ± 4.4 nm AgMUNH2 NPs at the 
maximum concentration (0.72 µM) posed a small impact on cell growth. (D) Oflx at 
concentration (a) 0.06, (b) 0.11, (c) 0.22, (d) 0.42 and (e) 0.720 (f) 0.0 µM . The scale 
bars A, B,C, D are 5 µm. 
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Figure 21: Plot of # of Cells (y1) versus the concentration, MIC50 is calculated from 
using exponential decay with y=a exp(-bx) equation at 18 h. 
 
A and B MIC of Oflx in WT and ΔBmrA were imaged. (a) 2.4 ± 0.7 nm AgMUNH2 (b) 
13.0 ± 3.1 nm AgMUNH2 (c) 92.6 ± 4.4 nm AgMUNH2 (d) 2.4 ± 0.7 nm AgMUNH-Oflx y
1 
WT= 527.5e
(-4.575c), R2 = 0.958 ; y1 ΔBmrA= 560.3e
(-4.008 c), R2 = 0.964, (e) Oflx alone y1 WT= 
501.6e(-5.600c), R2 = 0.974 ; y1 ΔBmrA= 514.9e
(-10.26c) R2 = 0.987 ,(f) 13.0 ± 3.1 nm 
AgMUNH-Oflx y1 WT= 524.4e
(-9.631c), R2 = 0.956 ; y1 ΔBmrA= 520.1e
(-17.150c), R2 = 0.981 and 
(g) 92.6 ± 4.4 nm AgMUNH-Oflx y1 WT= 496e
(-55.15c), R2 = 1.00 ; y1 ΔBmrA= 526.0e
(-45.36c), 
R2 = 0.999. 
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We saw a size dependent inhibitory effect in both strains. No strain dependency 
was observed, which may be due to the concentration being too high or low, or the cells 
may have already acquired resistance. 
 
We saw differences in the MIC results between two unique strategies, either by 
specifically measuring absorbance (optical density) at 600 nm (OD600nm) (Figure 18) or 
by counting the number of bacterial cells from single cell analysis contained slides 
(Figure 21). This may be due to the volume of samples used for the preparation of 
slides which was different from the volume used for measurements of optical density 
and sample size.  
 
 
SUMMARY:  
We successfully synthesized three different sized nano-carriers (AgMUNH2 NPs) 
and antibiotic drug nano-carriers (AgMUNH-Oflx NPs) of 2.4 ± 0.7 nm, 13.0 ± 3.1 nm 
and 92.6 ± 4.4 nm. We studied the growth curve and efflux mechanism of cells in the 
standard and modified medium. We came to the conclusion that cells are growing 
normally in modified medium and that efflux function is almost same in the standard 
medium. We used drug nano-carriers to study the minimum inhibitory concentration in 
gram-positive bacteria B.subtilis. We saw a size-dependent inhibition of bacteria cells. 
In conclusion 2.4 ± 0.7 nm AgMUNH-Oflx NPs was found to be less toxic compared with 
Oflx alone. 13.0 ± 3.1 nm AgMUNH-Oflx NPs were toxic and 92.6 ± 4.4 nm AgMUNH-
Oflx NPs were more toxic indicating that a smaller size NPs are biocompatible and can 
be used in diagnosis or as a sensor whereas larger size can be used for the treatment 
of diseases. As seen in dark-field optical imaging, cells did not divide properly indicating 
Oflx mechanism is inhibiting DNA gyrase. We used AgMUNH2 NPs and we did not see 
any inhibitory effect. Instead saw cells grow normally proving that AgMUNH2 NPs are 
biocompatible. Our studied showed that the nanoparticles functionalized with the drug 
and demonstrated a size-dependent and antimicrobial effect. These findings suggest 
that nanoparticles functionalized with drugs are an effective way to treat of infectious 
diseases and cancer. The dosage of a drug can be lowered significantly when 
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functionalized with nanoparticles which in turn, could reduce side effects of the drug 
alone. We can functionalize nanoparticles with certain polymers in such a way that the 
drug is released only in the targeted site. We would like to study efflux function of ABC 
transporter antibiotic drug nano-carriers in B.subtilis. 
 
 
METHODS 
Reagents and Supplies 
Silver nitrate (99.9%), sodium citrate dihydrate (99%), sodium borohydride 
(98%), hydrogen hydroxide (30%), polyvinylpyrrolidone (PVP), sodium chloride, sodium 
phosphate , sodium phosphate monobasic monohyrdate, 11-amino-1-undecanethiol 
hydrochloride (MUNH2, 99%), Luria-broth (LB) powder, yeast extract, sodium chloride 
and 2-(N-morpholino)ethanesulfonic acid were purchased from Sigma-Aldrich. Ofloxacin 
powder (≥98%) purchased from Enzo life science 1-Ethyl-3-[3-dimethylaminopropyl]-
carbodiimide hydrochloride (EDC, 99%) and N-hydroxysulfosuccinimide (sulfo-NHS, 
98.5%) were purchased from Pierce. Silver perchlorate monohydrate (99%) was 
purchased from Alfa Aesar. Live/dead BacLight viability and counting assay, Hoechst 
were purchased from Invitrogen. All reagents were used as received. The nanopure 
deionized (DI) water (18 MΩ water, Barnstead) to prepare solutions, including a 
commonly used LB medium (1% tryptone, 0.5% yeast extract and 0.5% NaCl in DI 
water, pH = 7.2) and a modified LB medium (1% tryptone, 0.5% yeast extract and 0.1% 
NaCl in DI water, pH = 7.2). 
 
Cell Lines, Cell Culture Media, Cell Culture, and Characterization 
Two strains of gram-positive bacterial cells (Bacillus subtilis): WT (normal 
expression BmrA) purchased from Bacillus Genome stock center (BGSC) and Delta 
BmrA previously named as ΔYvcC, a mutant strain that is devoid of the BmrA were 
provided by J. M. Jault.66 were used for this study. We first pre-cultured the cells in the 
commonly used medium for 12 h. We then cultured the cells using standard LB medium 
and the modified LB medium in a shaker (MaxQ 5000, 200 rpm, 37 °C) for another 8 h. 
We followed the cell growth in each respective medium over time and characterized the 
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cell growth curves by measuring OD600 nm of cell suspension in the medium every 30 
min over 8 h of cell culture. We studied the viability of the cultured cells by the end of 
cell culture at single cell resolution using live/dead BacLight viability and counting 
assay.46 The cells in the medium were imaged in the micro-chamber using dark-field 
optical microscopy and epi-fluorescence microscopy. The green fluorescence cells 
(peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm) and red 
fluorescence cells (peak wavelength of fluorescence spectra of propidium iodide, λmax = 
610 nm) were determined and counted as live and dead cells, respectively. 
 
By the end of the cell culture, we harvested the cells using centrifugation 
(Beckman JA-14, 7500 rpm), and rinsed them with the PBS buffer (0.5 mM phosphate 
buffer, 1.5 mM NaCl, pH 7.2) three times via centrifugation. We then suspended the 
cells in the PBS buffer and adjusted the cell suspension concentration (OD600 nm = 0.1) 
in the buffer. We characterized the efflux function of BmrA membrane transporters of 
live cells cultured in each medium by continuously measuring fluorescence intensity of 
Hoechst dye of the cell suspension (OD600 nm = 0.1) containing 2 µM Hoechst dye in 
real-time (3 s time interval) for 2 h using a fluorescence spectrometer (Perkin-Elmer 
LS50B) with the excitation and emission wavelengths at 350 and 488 nm, respectively.  
 
Synthesis and Characterization of Ag NPs  
Three different sized Ag NPs with diameters of (2.4 ± 0.7), (13.0 ± 3.1), and (92.6 
± 4.4) nm were synthesized, purified and characterized as we reported previously.35, 37, 
40 Briefly, we synthesized Ag NPs with diameters of 2.4 ± 0.7 nm by adding NaBH4 (150 
μL, 100 mM) into a stirring mixture (42.3 mL) of silver nitrate (0.11 mM), sodium citrate 
(1.91 mM), PVP (0.052 mM), and hydrogen peroxide (25 mM) that were freshly 
prepared using nanopure water.35, 37 We stirred the solution at room temperature for 
another 3 h and filtered the solution using 0.2 μm membrane filters. We prepared Ag 
NPs with diameters of 13.0 ± 3.1 nm by rapidly adding ice-cold AgClO4 (2.5 mL of 10 
mM) into a stirring ice-cold mixture (247.5 mL) of sodium citrate (3 mM) and NaBH4 (10 
mM). We stirred the solution at room temperature for 4 h, and filtered it using 0.2 µm 
filter.40 We synthesized (92.6 ± 4.4) nm Ag NPs by adding sodium citrate (10 mL, 34 
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mM) into a refluxing (100C) aqueous solution of 3.98 mM AgNO3 (500 mL). We stirred 
the mixtures for 35 min, and cooled the solution to room temperature. We then added 
additional 2.5 mM sodium citrate as a stabilizer into the solution, and filtered the solution 
using 0.2 µm filter.40 
 
We purified each NP solution by thoroughly washing the NPs three times with the 
DI water using centrifugation immediately after the synthesis. We characterized the NP 
concentrations, the LSPR images and spectra of single NPs, and sizes of single NPs 
using UV-vis spectroscopy (Hitachi U-2010), dark-field optical microscopy and 
spectroscopy (DFOMS), high-resolution transmission electron microscopy (HRTEM) 
(JEOL, JEM-2100F). Our setup for DFOMS is explained in our previous studies.32, 35-38, 
40, 42-44, 48-49
 Our DFOMS is equipped with a dark-field optical microscope, which includes 
a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× objective (Nikon Plan fluor 
100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth of field (focus) of 190 nm, a 
charge coupled device (CCD) camera (Micromax, Roper Scientific) and Multispectral 
Imaging System (Nuance, CRI). 37 ,50 
 
Synthesis and Characterization of Drug Nano-Carriers (AgMUNH-Oflx NPs)  
We added MUNH2 (1 mL, 100 mM, in ethanol) into each of the freshly prepared 
Ag NPs (100 mL, 50 nM, 3.3 nM and 30 pM) of three different sized Ag NPs (2.4 ± 0.7, 
13.0 ± 3.1, and 92.6 ± 4.4 nm), respectively. We stirred the mixtures for 24 h to attach 
MUNH2 onto the surface of NPs via the interaction of thiol groups with the NPs to 
prepare functional AgMUNH2 NPs. We washed the AgMUNH2 NPs thoroughly three 
times with nanopure water to remove excess MUNH2 using centrifugation (Beckman 
Optima L90k, 4 C). We suspended the half of AgMUNH2 NPs solution (50 mL) in the 2-
(N-morpholino) ethanesulfonic acid (MES) buffer (50 mM, pH 5.0) right before 
conjugating them with Oflx. We suspended the other half of AgMUNH2 NPs solution (50 
mL) in the PBS buffer (pH 7.0) right before control experiment. Note that the AgMUNH2 
NPs were suspended in DI water for the storage, and only suspended in the respective 
buffer right before the experiment. After each washing and re-suspension step, we 
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immediately characterized the concentrations, optical properties and sizes of each sized 
AgMUNH2 NPs using UV-vis spectroscopy, DFOMS and DLS, respectively.  
 
We then conjugated the amine groups of each sized AgMUNH2 NPs (50 mL) with 
the carboxyl group of Oflx via peptide bonds using a two-step method via EDC and s-
NHS as mediators (Fig. 12). 67-68 We first dissolved Oflx in 0.5 M HCl (1 mL) and then 
diluted it using MES buffer (pH 5.0). We added the EDC (100 μL, 100 mM) and s-NHS 
(100 L, 500 mM) into the Oflx solution (3 mL, 50 mM), and stirred it at room 
temperature for 40 min, to form Oflx-s-NHS esters. We added 2-mercaptoethanol (10 
μL,14.3 M) to quench the excess EDC. We added the Oflx-s-NHS esters (1 mL, 3 mM) 
to the AgMUNH2 NPs (100 mL, 50 nM for 2.4 nm, 3.3 nM of 13 nm and 30 pM for 93 nm 
NPs, in the MES buffer, pH 5.0), and well mixed the solution using a rotary shaker at 
room temperature for 3 h, to synthesize the AgMUNH-Oflx NPs, respectively.  
 
We purified the drug nano-carriers (AgMUNH-Oflx NPs) by washing the nano-
carriers with DI water three times and stored at 4C for the future use. We suspended 
each sized nano-carrier in the PBS buffer (pH 7.0) right before the experiment for the 
study of their inhibitory effect on cell growth. After each washing and right after NPs 
suspended in the solution, we immediately characterized the concentrations, optical 
properties and sizes of each sized AgMUNH2 NPs using UV-vis spectroscopy, DFOMS 
and DLS, respectively. We measured the UV-vis absorbance spectra of various 
concentrations of each sized nano carriers (AgMUNH-Oflx NPs) in the solution and 
plotted the peak absorbance of the NPs versus nano-carriers concentration to construct 
a calibration curve and determine its absorption coefficients for 2.4 ± 0.7, 13.0 ± 3.1 and 
92.6 ± 4.4 nm, respectively. 
 
We measured the UV-vis absorbance spectra of various concentration of Oflx 
alone (absence of NPs) in the solution, and plotted the peak absorbance at 288 nm 
versus Oflx concentration to construct a calibration curve and determine its absorption 
coefficient (ε288 nm = 7.8x10
3 M-1cm-1 and ε330 nm = 2.4x10
3 M-1cm-1). We subtracted UV-
vis absorption spectra of AgMUNH2 NPs from that of the same sized and concentration 
of AgMUNH-Oflx NPs to obtain UV-vis absorption spectra of Oflx conjugated with the 
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AgMUNH2 and used absorption coefficient of Oflx to determine its concentration. We 
also determine the NP concentration based upon the peak absorbance of the plasmonic 
absorption spectra of the NPs. By dividing the concentration of Oflx with concentration 
of NPs in the same AgMUNH-Oflx NPs solution using UV-vis absorption spectroscopy, 
we determined conjugation ratios of antibiotics (Oflx) to NPs for each sized drug nano 
carriers.  
 
 
Inhibitory Effects of Drug Nano-Carriers at Single Cell Resolution 
We cultured the cells (WT or ΔBmrA) in the modified LB medium (4 mL) 
containing a dilution series of Oflx alone, a given sized drug nano-carriers (AgMUNH-
Oflx NPs) and AgMUNH2 NPs (control experiments) by inoculating 10
4 pre-cultured cells 
into the medium, and vigorously shaking the solution (200 rpm, 37oC) over 18 h.  
 
The dilution series contains 0, 0.06, 0.11, 0.22, 0.42, and 0.72 μM of free Oflx or 
Oflx conjugated with the NPs (AgMUNH-Oflx NPs) for WT and ΔBmrA, which is 
correlated with the concentrations of drug nano-carriers (NP concentrations): (i) 0.06, 
0.13, 0.25, 0.49, and 0.83 nM for diameters of NPs of (2.4 ± 0.7) nm with ratio of 
8.6x102 Oflx molecules per NP; (ii) 5.83x10-3, 1.17x10-2, 2.33x10-2, 4.45x10-2, and 
7.63x10-2 nM for diameters of NPs of (13.0 ± 3.1) nm with ratio of 9.4x103 Oflx 
molecules per NP; (iii) 8.49 x10-2, 1.71x10-1, 3.40x10-1, 6.48x10-1,and 1.11 pM for 
diameters of NPs of (92.6 ± 4.4) nm with ratio of 6.4x105 Oflx molecules per NP. The 
control experiments include the LB medium alone (absence of the cells) and the WT 
cells cultured under the same condition and at the same time in the medium containing 
0.83 nM, 7.63x10-2 nM or 1.11 pM AgMUNH2 NPs (in the absence of Oflx) with the 
diameters of Ag NPs of (2.4 ± 0.7, 13.0 ± 3.1 or 92.6 ± 4.4 nm), respectively.  
 
 
We sampled the cell culture suspension every 6 h and quantitatively determined 
the cell concentration by measuring OD600 nm in the cuvette using UV-vis absorption 
spectrometer and imaging the number of single cells in a micro-chamber using dark-
field optical microscopy. We plotted OD600 nm and the number of the cells of the cell 
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suspension over time to determine the duration that is needed for the cells to reach the 
confluence. We then plotted OD600 nm and the number of the cells of the cell suspension 
at 18 h versus the concentration of Oflx alone, or a given sized drug nano-carriers or 
AgMUNH2 NPs to determine the minimum inhibitory concentration (MIC) of Oflx and the 
given drug nano-carriers for each cell strain. 
 
Data Analysis and Statistics  
We characterized sizes and shapes of Ag NPs using TEM, and LSPR spectra of 
single Ag NPs, AgMUNH2 NPs, and AgMUNH-Oflx using DFOMS. For each size and 
each type of the NPs, we imaged a minimal of 100 NPs for each measurement, and 
repeated each experiment three times. Thus, a minimal of 300 NPs was characterized 
using TEM and DFOMS.  
 
For single cell imaging experiment, we sampled the cell culture suspension every 
6 h over 18 h and imaged single cells in a micro-chamber using dark-field optical 
microscopy. We acquired five representative images of each cell culture suspension in 
the same detection volume to track the cell growth in the medium and to study the 
concentration, time, size, and BmrA strain dependent inhibitory effects of Oflx and nano-
carriers. Each experiment was repeated three times. We used average of three 
measurements with standard deviations for UV-vis whereas as for imaging used 
cumulative of three runs for each sized of drug nano-carriers to determine the MIC.  
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CHAPTER IV 
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF 
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 2.0 NM DRUG-NANO-CARRIERS 
INTRODUCTION: 
Quinolones are broad spectrum antimicrobial agents used for the treatment of 
chronic bronchitis, urinary tract infections, and sexually transmitted diseases.51,3 As 
research advances quinolone derivatives are developed to reduce side effects and 
increase the bioavailability of drugs; among them is fluoroquinolone such as ofloxacin 
(Oflx).52 Studies have shown that resistances for antimicrobials or other drugs are 
dependent on efflux out of cells through ABC transporters. The ABC transporters 
constitute one of the largest and most diverse membrane protein super-families found in 
living organisms.62 The ABC transporter is involved in efflux of substances either in a 
unidirectional or bidirectional manner even against concentration gradients are 
remarkably associated with resistance to drugs in humans.62 This raises a major 
concern in treatment of disease.62 The ABC transporter contains four domains: two 
transmembrane domains (TMD) which specifically bind to substrates, and two 
nucleotide-binding domains (NBD) which bind to ATP to release energy driving 
extrusion of the drug from the cell.  
 
Currently, nanoparticles have a wide variety of applications in multiple fields.54 
Metal nanoparticles have peculiar physical and chemical properties when compared 
with bulk metals, hence their synthesis and applications in the biomedical field have 
increased drastically in the last decade.54 In the biomedical field, they are used for 
sensing, drug delivery, and for therapeutic effects.58 Silver nanoparticles (Ag NPs) with 
unique optical, electronic, and antibacterial properties have been widely used in bio-
sensing, photonics, electronics, and antimicrobial applications, among others.55, 58 In the 
clinical field, Ag NPs are used as surgical dressings, for wound healing, and as anti-
neoplastic. Some of their physicochemical properties such as size, shape, and surface 
charge are important to determining the biological interaction.54, 
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Silver nanoparticles (Ag NPs) have unique optical properties, notably localized 
surface plasmonic resonance (LSPR) which is the size dependence of the optical color 
allowing for size characterization.34, 36, 39 This is an important phenomenon to ensure 
nanoparticles are of correct size. Metal nanoparticles also do not exhibit photo-blinking 
or photo-decomposition, which is crucial when monitoring cells for long durations, since 
the intensity of nanoparticles will be constant.34, 36, 39, 61-63 Furthermore, the surfaces of 
nanoparticles can be modified to identify a certain type of cells.35 Our group has 
developed a wide range of colored single-molecule nanoparticle optical probes and 
biosensors (SMNOBS) that are utilized for the imaging and characterization of 
molecular mechanisms in single live cells.59  
In previous studies, we studied the efflux function of Ag NPs with average 
diameters of 13.1 ± 2.5 nm and 91.0 ± 9.3 nm in P.aeruginosa (a gram-negative 
bacteria).40 We also studied the efflux function of Ag NPs with an average diameter of 
11.8 ± 2.6 nm and 97 ± 13 nm in B.subtilis (gram-positive bacteria).39,38 Recently, we 
used Ag-peptides positively and negatively charged, with diameters of 11.5 ± 2.9 nm 
and 11.3 ± 2.5 nm and studied charged-dependent efflux function in B.subtilis. 65 
The study of drug efflux function of transporter allows us to investigate how 
resistance is acquired by bacterial cells. We used B.subtilis (a gram-positive bacteria) 
as a model organism as it has a family of 78 ABC transporters.62,63,61 In this study, we 
synthesized 2.4 ± 0.7 nm AgMUNH2 NPs and AgMUNH-Oflx NPs and studied the efflux 
function of NPs in two B.subtilis strain WT with a normal expression level of BmrA, and 
ΔBmrA with a non-expression of BmrA. In this study, we conjugated many Oflx drug 
molecules on single NPs. Thus, this study of drug carrier gives us more details about 
how drugs are effluxed out cells.  
Results and Discussion  
We first synthesized 2.4 ± 0.7 nm Ag NPs as described in methods.37 We then 
functionalized the Ag NPs using a monolayer of 11-amino undecanethiol hydrochloride 
(MUNH2). We then AgMUNH2 linked with ofloxacin (Oflx) by a peptide bond between 
the amine group of MUNH2 and the carboxyl group of Oflx. We then washed AgMUNH-
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Oflx NPs to remove the unreacted Oflx. The advantages of covalent conjugation were 
that NPs were stable in the buffer and the conjugation ratio remained constant.  
We determined the conjugation ratio of Oflx to NP using UV-vis spectroscopy. 
We constructed a calibration curve of Oflx solution with an extinction coefficient (ε) at 
7.8 x 103 M-1 cm-1 at 288 nm wavelength. The UV-vis spectra of AgMUNH2 and 
AgMUNH-Oflx of NPs were measured. The UV-vis spectra of conjugated Oflx were 
obtained by subtracting AgMUNH-Oflx NPs spectra with AgMUNH2 NPs spectra. The 
absorbance of Oflx was calculated by corresponding peak height at 288 nm which was 
used to determine the concentrations of conjugated Oflx. The conjugation ratio of 
AgMUNH-Oflx NPs with Oflx was calculated by dividing the concentration of Oflx by the 
concentration of AgMUNH-Oflx NPs we found conjugation ratio as 1: 8.6 x 10
2 for NP: 
Oflx. 
Efflux function of single membrane Transporter in Single Live cells  
The distinctive plasmonic properties (LSPR, color) of single AgMUNH-Oflx NPs 
and AgMUNH2 NPs were used to study the transport of single NPs in and out of single 
live cells (WT and ΔBmrA), and also to distinguish between cell debris. Cell debris does 
not have LSPR and appears as white under DFOMS. DFOMS of the WT cells is shown 
in Figure 22 for AgMUNH-Oflx NPs and in Figure 23 for AgMUNH2 NPs. From dark-field 
images, we measured the cross section of a single bacteria cell (rod-shaped cell) with a 
length of 2 µm and width of 0.5 µm. Surface and base membranes of single live cells 
are imperceptible under dark-field, demonstrating that the focal plane of dark-field 
empowers us to image thin-layer section of single live cells with single NPs. Since NPs 
have scattering intensity this was used to determine whether NPs are intracellular or 
extracellular. When NPs were inside the cell (intracellular NP) scattering intensity was 
lower and NPs appeared dimmer (Fig.22,23B) whereas when outside the cell 
(extracellular NP), the scattering intensity was brighter (Fig.22,23C). We proved that by 
using scattering intensity we can distinguish between intracellular and extracellular NPs 
allowing the study of the efflux function of single membrane transporters in real time 
imaging of single live cells.34-36, 38-39, 44, 61, 63  
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Figure 22: Imaging of single intracellular 2.4 ± 0.7 nm AgMUNH-Oflx NPs in single 
living B.subtilis bacterial cells using DFOMS.  
(A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNH-Oflx 
NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of single 
WT cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color 
images intracellular AgMUNH-Oflx NPs. (C) Zoom-in images of single WT cells show (i, 
iii) are CCD images pseudo colors were added and (ii, iv) color images extracellular 
AgMUNH-Oflx NPs. The scale bar in A and B are 10 and 2 µm, respectively. (D) LSPR 
spectra of 2.4 ± 0.7nm AgMUNH-Oflx NPs show peak wavelength at 568 nm and 586 
nm.  
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Figure 23: Imaging of single intracellular 2.4 ± 0.7nm AgMUNH2 NPs in single 
living B.subtilis bacterial cells using DFOMS. 
 (A) The representative image of bacterial WT cells incubated with 1.4 nM AgMUNH2 
NPs showing intracellular nano-carriers as squared. (B) Zoom-in images of single WT 
cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color images 
intracellular AgMUNH2 NPs. (C) Zoom-in images of single WT cells show (i, iii) are CCD 
images pseudo colors were added and (ii, iv) color images extracellular AgMUNH2 NPs. 
The scale bar in A and B are 10 and 2 µm. 
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Accumulation Rates of Intracellular AgMUNH-Oflx and AgMUNH2 NPs in BmrA 
We examined the accumulation rates of AgMUNH-Oflx NPs and AgMUNH2 NPs 
in both WT and ΔBmrA to determine the rate of accumulation of NPs in single BmrA live 
cells. The results in Figure 24 and Table 3 show accumulation rates calculated from the 
slope of the plot of intracellular NPs in single BmrA cells. The accumulation rate of 1.4 
nM AgMUNH-Oflx NPs in WT was 0.43 NPs/min, whereas with AgMUNH2 NPs was 
0.74 NPs/ min at 41.5 min. The ratio of AgMUNH-Oflx to AgMUNH2 is 0.6. In ΔBmrA the 
accumulation rates were 0.86 NPs/ min and 1.39 NPs/min for AgMUNH-Oflx and 
AgMUNH2 NPs respectively, at 41.5 min. The ratio of AgMUNH-Oflx to AgMUNH2 NPs 
was also 0.6. As ΔBmrA was a devoid of pump activity, it accumulated more NPs inside 
the cells.  
 
 
 
Table 3: Study of Accumulation Rates and Number of Intracellular Single 2.0 nm NPs in 
Single Live Cells 
Diameter  
(nm)a 
C NPs 
(nM) 
NPs 
Accumulation  
Rate (NPs min-1)b 
Number of 
Intracellular NPs 
(min)c 
WT ΔBmrA WT ΔBmrA 
2.4 ±0.7 
1.4 nM 
AgMUNH-Oflx 0.43 0.86 33 70 
AgMUNH2 0.74 1.39 60 114 
0.7 nM 
AgMUNH-Oflx 0.38 0.49 32 39 
AgMUNH2 0.29 0.98 25 83 
 
a Diameter of Ag NPs measured by TEM; 
b Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure 
25 and 26); 
c Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation 
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Figure 24: Study of accumulation kinetics of single AgMUNH-Oflx NPs and 
AgMUNH2 NPs in single live cells.  
Plots of number of intracellular NPs in (A) WT and (B) ΔBmrA cells (a) 1.4 nM 
AgMUNH2 NPs (b) 1.4 nM AgMUNH-Oflx NPs were incubated for 2 h. The points 
represent the sum of three repeated experiments.  
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Entry of NPs into the cells was not hindered by AgMUNH-Oflx NPs or AgMUNH2 
NPs. AgMUNH-Oflx NPs accumulated less than AgMUNH2 NPs in both strains, 
indicating that the AgMUNH-Oflx NPs is also extruded much faster than the AgMUNH2 
NPs. Moreover, in bacterial cells (B.subtilis) do not have alternative mechanisms such 
as endocytosis, pinocytosis, and exocytosis mechanism for efflux of substrates. 
Concentration-dependent accumulation rates of single AgMUNH-Oflx and 
AgMUNH2 NPs in BmrA.  
We were also interested in knowing whether the NPs conjugated with antibiotics have 
similar characteristics of concentration-dependent efflux kinetics as antibiotics alone. 
The results from Figure 25 show that as concentration increased from 0.7 nM to 1.4 nM, 
the number of intracellular AgMUNH-Oflx NPs increased from 39 to 70 in single live 
ΔBmrA with accumulation rates of 0.49 and 0.86 NPs/min respectively; from this we can 
conclude that accumulation of NPs in single live ΔBmrA increased proportionally with 
concentration of AgMUNH-Oflx NPs. Whereas as in single live WT the number of 
intracellular AgMUNH-Oflx NPs was 32 to 33 with accumulation rates of 0.38 and 0.43 
NPs/min during the first 41.5 min, indicates that the number of intracellular AgMUNH-
Oflx does not increase with the concentration in this strain of bacteria. We also studied 
efflux function of cells (WT, ΔBmrA) using Hoechst dye. Cells are incubated with 2 µm 
dye and observed the time course of fluorescence intensity for 40 min. From Figure 25C 
as time proceeded, from 0-15 min, the amount of Hoechst dye is accumulating more in 
ΔBmrA than in WT (Figure 25Cb) and after 15 min, cells reached uptake saturation and 
remained constant for 40 min, whereas in WT (Figure 25Ca) it remained constant 
throughout 40 min.  
In contrast with results from AgMUNH-Oflx NPs, as concentration increased from 
0.7 nM to 1.4 nM the number of intracellular AgMUNH2 NPs increased from 93 to 165 in 
single live ΔBmrA with accumulation rates of 0.98 and 1.39 NPs/min (Figure 26). While 
in single live WT, the number of intracellular AgMUNH2 NPs increased from 26 to 60 
with accumulation rate of 0.29 to 0.74 NPs/min during the first 41.5 min. The results 
from AgMUNH2 NPs we can conclude that we accumulation of NPs in single live WT 
increased proportionally to the concentration of AgMUNH2 NPs but not in ΔBmrA.  
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Figure 25: Study of efflux kinetics of BmrA membrane transporter using 2.4 ± 0.7 
nm AgMUNH-Oflx NPs. 
 (A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 1.4 
nM (a) ΔBmrA and (b) WT. (B) The number of intracellular AgMUNH-Oflx NPs in 
B.subtilis incubated with 0.7 nM (a) ΔBmrA and (b) WT were plotted over time. (C) Time 
course of fluorescence intensity of intracellular Hoechst dye for (a) ΔBmrA and (b) WT 
cells incubated with 2 µM Hoechst dye for 40 min (Ex : 350 nm and Em : 488 nm) 
showed accumulation of intracellular Hoechst dye depends on the expression of 
B.subtilis. 
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Figure 26: Study of efflux kinetics of BmrA membrane transporter using 2nm 
AgMUNH2 NPs. 
(A) Plots of number of intracellular AgMUNH2 in B.subtilis incubated with 1.4 nM (a) 
ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis 
incubated with 0.7 nM (a) ΔBmrA and (b) WT. 
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Taken together, the results suggest that with AgMUNH-Oflx NPs showed concentration-
dependent efflux kinetics as antibiotics even though we functionalized with 8.6x102 Oflx 
on single NPs. These finding indicate that AgMUNH-Oflx NPs enter the cell through 
passive diffusion and efflux out leading to lower accumulation rates in WT when 
compared with ΔBmrA (devoid of pump). Interestingly, the results show that even such 
smaller size NPs (2.4 ± 0.7 nm) can be effluxed out and can be used as diagnosis 
probes. To our knowledge, no one has reported efflux kinetics with such smaller sized 
NPs and functionalized with AgMUNH-Oflx along with AgMUNH2 (control NPs).  
 
Characterization of Viability of Single Live Cells 
The viability of single cells with NPs is very important since NPs are 
functionalized with MUNH2 and Oflx. We incubated cells (WT, ΔBmrA) with NPs 
(AgMUNH-Oflx and AgMUNH2) for 2 h and at the end of the experiment; the viability of 
cells was measured by using a live/dead BacLight assay. This assay contained two 
fluorescent dyes: SYTO9 a green fluorescent (λmax = 520 nm) in which the nucleic acid 
stain in live cells appears in green fluorescence. Propidium iodide is a red florescent 
(λmax = 610 nm) which penetrates into damaged or disintegrated cells appearing in red 
fluorescence. Figure 27 shows representative optical images (Fig 27a) and green 
fluorescence (Fig 27b) of ΔBmrA and WT with and without AgMUNH-Oflx NPs in single 
cells. We counted the number of live and dead cells and calculated percentage of viable 
cells by dividing the number of live cells over the total number of the cells. Results 
showed that 99-100% of cells viable for both strains (Fig 27C). Figure 28 shows 
representative optical images (Fig 28a) and green fluorescence (Fig 28b) of ΔBmrA and 
WT with and without AgMUNH2 NPs in single cells. Results showed that 98-100% of 
cells viable for both strains (Fig 28C). From these viability assays, we can conclude that 
both AgMUNH-Oflx and AgMUNH2 are biocompatible to cells at the concentration of 1.4 
nM. 
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Figure 27: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay.  
(a)  Dark-field optical image and (b) fluorescence image of single bacterial cells (A) 
ΔBmrA (B) WT cells, incubated with 1.4 nM AgMUNH-Oflx NPs over the duration of 
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, 
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a, 
b) 1.4 nM AgMUNH-Oflx NPs and (c, d) 0.7 nM AgMUNH-Oflx NPs, indicate that 99-
100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The scale 
bar is 5 µm. 
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Figure 28: Characterization of the viability of single bacterial cells using live/dead 
BacLight viability and counting assay.  
(a)  Dark-field optical image and (b) fluorescence image of single bacterial cells (A) 
ΔBmrA (B) WT cells, incubated with 1.4 nM AgMUNH2 NPs over the duration of each 
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating 
that cells are viable. (C) Plots of percentage of viable cells incubated with (a, b) 1.4 nM 
AgMUNH2 NPs and (c, d) 0.7 nM AgMUNH2 NPs, indicate that 99-100% of the cells are 
alive. Minimum 300 cells were assayed and analyzed. The scale bar is 5 µm. 
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SUMMARY  
We successfully synthesized 2.4 ± 0.7 nm Ag NPs, then functionalized them with 
a monolayer of MUNH2 and finally linked with Oflx via an amine group of AgMUNH2 NPs 
and the carboxyl group of Oflx by a peptide bond, to prepare AgMUNH-Oflx NPs. We 
found that the number of Oflx molecules on a single NP is 8.6x102 and used LSPR 
spectra to track the NPs in order to study the efflux function. We found that cells were 
biocompatible up to 1.4 nM concentrations and used this concentration to study the 
efflux kinetics in ABC transporter of B.subtilis in a single cell. We found the efflux of 
AgMUNH-Oflx NPs is slower when compared with AgMUNH2 NPs. The accumulation 
rates in WT (0.43 NPs/min) and ΔBmrA (0.86 NPs/min) for 1.4 nM AgMUNH-Oflx NPs, 
WT (0.74 NPs/min), and ΔBmrA (1.39 NPs/min) for 1.4 nM AgMUNH2 NPs, and the ratio 
of accumulation of AgMUNH-Oflx to AgMUNH2 NPs was found to be 0.6 for both 
strains. We also found a concentration-dependency in ΔBmrA treated with AgMUNH-
Oflx NPs, while WT cells did not , indicating that these nano-carriers also effluxed out 
similarly to antibiotics. To our knowledge, no one had studied efflux function using 
smaller sized NPs (2.4 ± 0.7 nm Ag NPs). We have already studied Ag NPs as probes 
to study efflux function and from this, we have proved even smaller nano-carriers can 
be used study efflux function. We further need to study larger sized drug nano-carriers 
(10-100 nm NPs) to determine the efflux function in ABC Transporter.  
 
METHODS 
Reagents and Supplies 
Sodium citrate dihydrate (99%), sodium borohydride (98%), hydrogen hydroxide 
(30%), polyvinylpyrrolidone (PVP), 2-mercaptoethanol (99%), 11-
mercaptoundecylamine (MUNH2, 99%), sodium chloride, sodium phosphate, sodium 
phosphate monbasic monohydrate, tryptone, yeast extract were purchased from Sigma-
Aldrich. Ofloxacin powder (≥98%) purchased from Enzo life science. 1-Ethyl-3-[3-
dimethylaminopropyl]-carbodiimide hydrochloride (EDC, 99%) and N-
hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from Pierce. Silver 
perchlorate monohydrate (99%) was purchased from Alfa Aesar. Live/dead BacLight 
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viability and counting assay, Hoechst 33342 dyes were purchased from Invitrogen. All 
reagents were used as received. The nanopure water (18.0 M water, Barnstead) was 
used to prepare all solutions and rinse glassware. 
Synthesis and Characterization of NPs  
As we described in previous papers, briefly 2.4 ± 0.7 nm Ag NPs were 
synthesized by preparing AgNO3 (0.11 mM), sodium citrate (1.91 mM), PVP (0.052 
mM), and H2O2 (25.0 mM) in nanopure water (42.3 mL) mixed and stirred constantly, 
then NaBH4 (150 μL, 100 mM) was added into the mixture, the solution color turned to 
light yellow, all solution were prepared freshly. After stirring for another 3 h, the solution 
was filtered using 0.2 μm membrane filters. The Ag NP solution was immediately 
washed using centrifugation and characterized using UV-vis spectroscopy (Hitachi 
U2010), our dark-field single nanoparticle optical microscopy and spectroscopy 
(SNOMS). TEM samples were immediately prepared and further characterized using 
high- resolution transmission electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).  
Our Dark-field Optical Microscopy (DFOMS) is equipped with a dark-field optical 
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× 
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth 
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral 
Imaging System (Nuance, CRI). 37,50 We explained development and application of 
DFOMS have been fully described in our previous studies.34-39, 42-44, 48, 50  
Synthesis of AgMUNH2 NPs 
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 2.4 ± 0.7 nm Ag NPs 
solution. The solutions then were stirred for 24 h to attach MUNH2 onto the surface of 
Ag NPs via their interaction of thiol groups with NPs. The AgMUNH2 NPs were washed 
twice by nanopure water to remove excess MUNH2 using centrifugation 30,000 rpm at 
4ºC for 60 min. The AgMUNH2 NPs were immediately characterized using UV-vis 
spectroscopy and DFOMS. 
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Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx) 
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of 
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators.67-68 Initially, 
ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer 
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the 
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-s-
NHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol. 
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL 
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature. 
The final products (AgMUNH-Oflx) were washed with 50 mM PBS using centrifugation 
.The pellets were redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes 
and optical properties were characterized using UV-vis spectroscopy and DFOMS.            
Cell Culture and Preparation 
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were 
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously 
named as ΔYvcC, a mutant strain that is devoid of the BmrA) were provided by J. M. 
Jault.66  
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of L-
broth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2) 
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured 
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured 
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10 
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in 
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used 
for the entire study. 
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Bulk Imaging of Single NPs in Single Living Cells  
The cell suspension (OD600nm = 0.7) containing 1.4 nM and 0.7 nM AgMUNH-Oflx 
NPs and AgMUNH2 NPs were prepared. The timer was started to record the incubation 
time as the NPs were added into the cell suspension. Following NP addition, we 
transferred the mixture (1.0 μL) into a freshly prepared micro-chamber (using nail 
polish) every 25 min and using DFOMS we imaged the cells at eighteen representative 
locations. This approach permitted us to image the massive amount of cells ( minimum 
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells) 
for each sample to gain sufficient statistics for probing the accumulation and efflux 
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and 
plotted them versus time to measure accumulation rates of single NPs for the cells over 
time (accumulation rate = slope of the plot).  
Fluorescence spectroscopy measurements 
Time-dependent of fluorescence intensity of 2.0 µM Hoechst dye incubated with 
the 3.0 mL cells (WT, ΔBmrA) measured in a 3 s interval using a fluorescence 
spectrometer (Perkin-Elmer LS50B). The excitation and emission wavelengths were 
350 and 488 nm, respectively. 
Cell Viability 
At the end of each experiment, the viability of the cells was characterized using 
live/dead BacLight bacterial viability and counting assay.46 We imaged the cells using 
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green 
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm) 
and red fluorescence cells (peak wavelength of fluorescence spectra of propidium 
iodide, λmax = 610 nm) as live and dead cells, respectively. 
Data Analysis and Statistics 
We acquired eighteen representative images of each cell suspension incubated 
with 1.4 or 0.7 nM NPs every 25 min (18 min for imaging and 7 min for the preparation 
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells. 
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Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were 
studied over 2 h for each measurement. Each experiment was repeated three times. 
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient 
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell 
resolution. The equilibrium times of accumulation of NPs in the cells were determined at 
the times when the accumulation rates of intracellular NPs remained unchanged over 
time. The amount of accumulated intracellular NPs for each strain refers to the amount 
of intracellular NPs at the equilibrium time.  
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CHAPTER V 
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF 
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 13.0 NM DRUG NANO-
CARRIERS 
 
INTRODUCTION 
In the treatment of bacterial diseases such as pneumonia, chronic bronchitis, and 
urinary tract infections, fluoroquinolone derivatives such as ofloxacin are often used.52 
However bacteria have acquired resistance towards many drugs due to multidrug 
resistance (MDR).3, 52 Resistance to a drug is attributed to MDR transporter, which 
extrudes drugs or other substances out of the cells.52,5 The MDR transporter is 
classified as two types which are a proton gradient and adenosine triphosphate (ATP) 
binding cassette (ABC) transporter by ATP hydrolysis.1 ABC transporter is found in both 
prokaryotes and eukaryotes and is involved in the transport of a variety of structurally 
similar compounds.3 The ABC transporter contains two transmembrane domains (TMD) 
and two nucleotide-binding domains (NBD).1, 3-5 Substrates specifically bind to the TMD 
and form a passage that allows substrates to cross the membranes. ATP hydrolysis by 
NBD provides energy for the transporter, which causes the substrates to efflux out of 
cells against the concentration gradient.1, 4-5 
  
The foremost question was how resistance is acquired and how structurally 
similar membrane transporters could extrude structurally unrelated substrates through 
ABC transporters by the efflux mechanism.1, 5 Many studies were done using x-ray 
crystallography and cryo-TEM at atomic resolution.1, 5, 69 However, none of them 
provided real-time information regarding how proteins specifically bind with substrates, 
how they lead to a change in conformation of membrane transporters, the efflux of 
substrates, or the crystallization of proteins. 
 
 Radioisotopes i.e., 14C or 3H and fluorescent dyes such as Hoechst dye, 
ethidium bromide or rhodamine in both mammal and bacterial cells can be used to 
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study the efflux kinetics of multidrug membrane tansporters.6-9 However, these present 
some disadvantages such as photo-bleaching and accumulation kinetics of substrates 
in bulk cells but not in single membrane cells. Hence, it is important to know efflux 
kinetics of substrates at the single cell level.  
 
Nanoparticles have become quite popular during the last decade due to their size 
and physicochemical properties. They are used in multiple fields such as probes-
diagnosis of diseases and isolation of cells, site specific drug delivery, and 
encapsulation of drugs etc.54-58 Metal nanoparticles like Silver nanoparticles (Ag NPs) 
are frequently used due to their plasmonic properties which in turn depend on the 
shape, size, and dielectric constant. 54-58 Dark-field optical microscopy and 
spectroscopy (DFOMS) which uses a halogen lamp as an illumination source is used to 
image and characterize single Ag NPs.34-35, 37, 39-40, 43-44, 49-50, 59 In our previous studies, 
we used localized surface plasmon resonance spectra (LSPR) and size-dependent 
scattering intensity of single NPs to determine the quantitative size of NPs in solution, 
single live embryos, and also in single live cells in real time.34-35, 37, 39-40, 43-44, 49-50, 59 
Since Ag NPs are photostable, we used them as probes to the study size-dependent 
efflux mechanism of the multidrug membrane in a single live cell at nm spatial and ms 
temporal resolution. 34-35, 37, 39-40, 43-44, 49-50, 59 We also functionalized the surface of NPs 
with a certain monoclonal antibody in order to identify a certain type of cells.59  
 
In previous studies, we used Ag NPs with an average diameter of 13.1 ± 2.5 nm 
and 91.0 ± 9.3 nm to study the efflux function in P.aeruginosa (a gram-negative 
bacteria).40 The efflux function was also studied using 12.3 ± 1.8 nm Ag NPs in E.coli (a 
gram-negative bacteria).21 We used Ag NPs with an average diameter of 11.8 ± 2.6 nm 
and 97 ± 13 nm to study the efflux function in B.subtilis (a gram-positive bacteria).39,38 
Recently, we also used a functionalized positively and negatively charged Ag-peptide 
with a diameter of 11.5 ± 2.9 nm and 11.3 ± 2.5 nm to study the charged-dependent 
efflux function in B.subtilis.65 We studied the efflux function of 2.4 ± 0.7 nm AgMUNH-
Oflx NPs (drug nano-carriers) in B.subtilis and found that even smaller sized NPs were 
effluxed out similar to antibiotics or drugs.  
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One of the key challenges for treating diseases is resistances to 
antibiotics/drugs. In this study, we used 13.0 ± 3.1 nm Ag NPs that were functionalized 
with Oflx molecules. We studied the efflux function in B.subtilis to better understand this 
process, which might depend on the size of nano-carriers and also on a number of 
carrier molecules attached on the surface of nano-carriers.  
 
RESULTS AND DISCUSSION  
Synthesis of AgMUNH-Oflx NPs (drug nano-carriers)  
We synthesized 13.0 ± 3.1 nm Ag NPs as explained in previous papers and 
methods.42-43 Ag NPs were purified and then functionalized with Oflx by two-step 
reaction process. First, we functionalized with a monolayer of MUNH2, and in step 2 
carboxyl group of Oflx was linked to the amine group of MUNH2 via the peptide bond. 
We determined the number of Oflx attached to single NPs and found it to be 9.4x103.22, 
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Efflux function of AgMUNH-Oflx NPs and AgMUNH2 NPs in B.subtilis 
Localized surface plasma membrane (LSPR) spectra (colors) of single AgMUNH-
Oflx and AgMUNH2 NPs were used distinguish between cell membranes and debris, 
which do not possess plasmonic properties. Thus LSPR spectra of single NPs allowed 
us to identify and track the single NPs intracellular and extracellular of single live cells 
(WT and ΔBmrA) using DFOMS. Dark-field optical images of single live WT cells (Fig. 
29) of AgMUNH-Oflx NPs and AgMUNH2 NPs (Fig. 30) showed cross sections of single 
rod-like bacterial cells. NPs appeared dimmer when NPs entered the cell membrane 
(Fig. 29B) for AgMUNH-Oflx NPs and (Fig. 30B) for AgMUNH2 NPs since the scattering 
intensity of NPs was lower due to the entry of NPs into the cell membrane. Dark-field 
illumination passes through the cell membrane to radiate and scatter the intensity of 
NPs. Intracellular NPs pass through the membrane to reach the detector and the cell 
membrane absorbs and scatters photons. 
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Figure 29: Imaging of single intracellular 13 ± 3.1 nm AgMUNH-Oflx NPs in single 
living B.subtilis bacterial cells using DFOMS. 
 (A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNH-
Oflx NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of 
single WT cells show (i, iii) are CCD images and (ii, iv) color images intracellular 
AgMUNH-Oflx NPs. (C) Zoom-in images of single WT cells show (i, iii) are CCD images 
were added and (ii, iv) color images extracellular AgMUNH-Oflx NPs. The scale bar in A 
and B are 10 and 2 µm, respectively. (D) LSPR spectra of 13 ± 3.1 nm AgMUNH-Oflx 
NPs show peak wavelength at 547 nm and 560 nm.  
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Figure 30: Imaging of single intracellular 13 ± 3.1 nm AgMUNH2 NPs in single 
living B.subtilis bacterial cells using DFOMS.  
 
(A) The representative image of WT bacterial cells incubated with 1.4 nM AgMUNH2 
NPs showing intracellular nano-carrier as squared. (B) Zoom-in images of single WT 
cells show (i, iii) are CCD images and (ii, iv) color images intracellular AgMUNH2 NPs. 
(C) Zoom-in images of single WT cells show (i, iii) are CCD images and (ii, iv) color 
images extracellular AgMUNH2 NPs. The scale bar in A and B are 10 and 2 µm. 
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 NPs appear brighter on the membrane and stuck outside the cells (Fig. 29C) for 
AgMUNH-Oflx NPs and (Fig. 30C) for AgMUNH2 NPs. We used the LSPR spectra and 
scattering intensity of single NPs and monitored functionalized NPs on the surface of 
NPs. In real time they were incubated with cells and transported across the cellular 
membrane over time using similar approaches as mentioned in previous reports. LSPR 
spectra of drug nano-carriers show in Figure 29D with peak wavelength at 547 nm and 
560 nm. 
 
If the NPs were aggregated they became the larger NPs and we would have 
seen a red shift of LSPR spectra and higher scattering intensity of single NPs. If Oflx or 
MUNH2 were released or detached from NPs surface, a blue shift of NPs would have 
been observed. This phenomenon was not observed, indicating that the NPs were 
stable in PBS buffer and in the cell over time.  
 
Accumulation of single AgMUNH-Oflx NPs and AgMUNH2 NPs in Single Live Cells  
 The accumulation rates of 13.0 ± 3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs 
were studied in B.subtilis WT and ΔBmrA (devoid pump) to determine the accumulation 
of intracellular NPs upon the nano-carriers type and the expression of BmrA in single 
live cells. The results as shown in Figure 31 and Table 4 demonstrated that the 
accumulation rate in WT (Fig. 31Ab) was 0.89 NPs/min at 41.5 min and the intracellular 
NPs were found to be 70, whereas in devoid pump ΔBmrA (Fig. 31Aa) was 1.22 
NPs/min at 41.5 and the intracellular NPs were found to be 101. From these, results it 
can be conclude that AgMUNH-Oflx NPs are effluxed out in WT but not in ΔBmrA 
indicating that drug nano-carriers are effluxed out similarly to drugs/antibiotics. This is 
similar to what we have seen previously for the study of smaller nano-carriers (2.4 ± 0.7 
nm). Bacteria cells do not have endocytosis, pinocytosis, and exocytosis mechanisms 
so NPs are not transported in or out of cells by these mechanisms. The size of NPs was 
13.0 ± 3.1 nm AgMUNH-Oflx NPs, and the conjugation ratio was 9.4x103 Oflx molecules 
on each NP.  
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Figure 31: Study of efflux kinetics of BmrA membrane transporter using 13 ± 3.1 
nm AgMUNH-Oflx NPs. 
 
 (A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 1.4 
nM (a) ΔBmrA and (b) WT. (B) Plots of number of intracellular AgMUNH-Oflx NPs in 
B.subtilis incubated with 0.7 nM (a) ΔBmrA and (b) WT.  
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Study of efflux kinetics of BmrA membrane transporter using 13 ± 3.1 
nm AgMUNH2 NPs. 
 
(A) Plots of number of intracellular AgMUNH2 NPs in B.subtilis incubated with 1.4 nM (a) 
ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis 
incubated with 0.7 nM (a) ΔBmrA and (b) WT. 
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Cells incubated with AgMUNH2 NPs from Figure 32 and Table 4 showed that the 
accumulation rate in WT (Fig. 32Ab) was 20.67 NPs/min at 41.5 min and the 
intracellular NPs were 1659 for 900 cells. In ΔBmrA (Fig. 32Aa) was 28.95 NPs/min at 
41.5 and intracellular NPs were 2328. From this, AgMUNH2 NPs also were effluxed out 
in the same way as AgMUNH-Oflx NPs. However, AgMUNH2 NPs accumulated more 
than AgMUNH-Oflx NPs indicating that NPs functionalized with Oflx are also effluxed 
out in a similar manner to drugs. This further emphasized that nano-carriers are effluxed 
out.  
 
 
 
Table 4: Study of Accumulation Rates and Number of Intracellular Single 13.0 nm NPs 
in Single Live Cells 
 
Diameter  
(nm)a 
C NPs 
(nM) 
NPs 
Accumulation  
Rate (NPs min-1)b 
Number of 
Intracellular NPsc 
WT ΔBmrA WT ΔBmrA 
13.0 ± 3.1 
1.4 nM 
AgMUNH-Oflx 0.89 1.22 70 101 
AgMUNH2 20.67 28.95 1669 2328 
0.7 nM 
AgMUNH-Oflx 0.38 0.53 30 46 
AgMUNH2 12.48 18.29 941 1451 
 
a Diameter of Ag NPs measured by TEM; 
b Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure 
33 ); 
c Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation 
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Figure 33: Study of concentration-dependent accumulation kinetics of single 13 ± 
3.1 nm AgMUNH-Oflx NPs and AgMUNH2 NPs in single live cells.  
 
Plots of number of intracellular NPs in (A, a , b ) WT and (B, a , b ) ΔBmrA cells that 
were incubated with (i) 1.4 AgMUNH-Oflx NPs, (ii) 0.7 nM AgMUNH-Oflx NPs , (iii) 1.4 
nM AgMUNH2 NPs (iv) 0.7 nM AgMUNH2 NPs , (b) is zoom in of (a). The points 
represent the sum of three repeated experiments. 
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Concentration-Dependent Study of Single NPs in Single Live Cells 
We further characterized the entry of single NPs into single live cells in order to 
determine drug nano-carriers had same characteristics of pump substrates (antibiotics). 
The results in Figure 33 showed that as the concentration of AgMUNH-Oflx NPs 
increased the number of intracellular NPs for both strains WT and ΔBmrA also 
increased. In WT the accumulation rate at 41.5 min was 0.38 and 0.89 NPs/min for 0.7 
nM and 1.4 nM respectively, which was 2.3 times higher than 0.7 nM.  
In ΔBmrA, the accumulation rate at 41.5 min was 0.53 and 1.22 NPs/min for 0.7 
nM and 1.4 nM respectively; even this was 2.3 times higher than 0.7 nM. From this, we 
can conclude that drug nano-carriers are not effluxed out in ΔBmrA due to the absence 
of BmrA transporter, whereas as in WT they are effluxed out leading to lower 
accumulation rate and with a lower intracellular NPs. 
 
Even AgMUNH2 NPs showed concentration-dependence. In Figure 33 the 
accumulation rate in WT was 12.48 and 20.67 NPs/min whereas ΔBmrA was 18.29 and 
28.95 NPs/ min at 41.5 min for 0.7 nM and 1.4 nM respectively. This was 1.7 and 1.6 
times higher than 0.7 nM for WT and ΔBmrA. The number of intracellular NPs in WT 
was 941 and 1659 for 0.7 nM and 1.4 nM indicating at least 1 NP/bacteria for 0.7 nM 
and 2 NPs/ bacteria for 1.4 nM was observed at 41.5 min whereas in ΔBmrA 2 
NPs/bacteria and 3 NPs/bacteria for 0.7 nM and 1.4 nM respectively.  
 
The concentration gradient leads to passive diffusion of NPs into cell membranes 
whereas NPs are effluxed out by hydrolysis of ATP upon binding with NBD of BmrA. 
This data demonstrated that AgMUNH-Oflx NPs efflux out much faster than AgMUNH2 
NPs. 
 
Characterization of Viability of Single Cells  
We also wanted to know the viability of single cells, if the cells were dead, and if 
NPs accumulated more, thus leading to an inaccurate conclusion. We used a live/dead 
BacLight assay, which contains a green fluorescent (λmax = 520 nm) nucleic acid SYTO9 
to stain live cells.46  
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Figure 34: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay.  
 
(A)  Dark-field optical image and (B) fluorescence image of single bacterial cells (a) 
ΔBmrA (b) WT cells, incubated with 1.4 nM AgMUNH-Oflx NPs over the duration of 
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, 
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a 
,b) 1.4 nM AgMUNH-Oflx NPs and (c, d) 0.7 nM AgMUNH-Oflx NPs , indicate that 99-
100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The scale 
bar is 10 µm. 
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Figure 35: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay.  
 
(A)  Dark-field optical image and (B) fluorescence image of single bacterial cells (a) 
ΔBmrA (b) WT cells, incubated with 1.4 nM AgMUNH2 NPs over the duration of each 
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating 
that cells are viable. (C) Plots of percentage of viable cells incubated with (a ,b) 1.4 nM 
AgMUNH2 NPs and (c ,d) 0.7 nM AgMUNH2 NPs , indicate that 99-100% of the cells are 
alive. Minimum 300 cells were assayed and analyzed. The scale bar is 10 µm. 
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Thus, live cells appear in green fluorescence and a red florescent (λmax = 610 nm) 
propidium iodide to penetrates into damaged or disintegrated cells appearing in red 
fluorescence. Cells (WT, ΔBmrA) were incubated with NPs (AgMUNH-Oflx and 
AgMUNH2) for 2 h and then live/dead BacLight assay was used to measure the viability 
at the end of the experiment. Representative images of ΔBmrA Figure 34A and Figure 
34B WT, optical images (Fig. 34a) and green fluorescence (Fig. 34b) with and without 
AgMUNH-Oflx NPs in single cells.  We calculated the percentage of viable cells by 
dividing live over a total number of cells (live and dead cells).From Figure 34C indicates 
that 99-100% of cells are viable for both concentration and strains, indicating AgMUNH-
Oflx NPs are biocompatible. Images of ΔBmrA are shown in Figure 35A, and Figure 
35B WT, optical images (Fig. 35a) and green fluorescence (Fig. 35b) with and without 
AgMUNH-Oflx NPs in single cells. From Figure 35C indicates that 100% of cells are 
viable for both concentrations and strains. Cells with AgMUNH2 NPs had a minimum of 
1 NP for lowest concentration of WT and a maximum of 4 NPs for ΔBmrA. Viable cells 
were present, indicating that AgMUNH2 NPs are biocompatible. 
 
SUMMARY 
We synthesized and characterized 13.0 ± 3.1 nm AgMUNH2 and AgMUNH-Oflx 
NPs. We determined the number of Oflx attached to the single NPs and found this 
number to 9.4x103. We tracked single NPs using LSPR spectra to study the efflux 
function of AgMUNH-Oflx and AgMUNH2 NPs of B.subtilis (WT and ΔBmrA). From 
viability data, we can conclude that when studying efflux function, 98-100% cells were 
live indicating that NPs (AgMUNH-Oflx and AgMUNH2) are biocompatible when cells 
are incubated with 1.4 nM. From the efflux function study, a concentration-dependence 
was observed in single live cells (WT and ΔBmrA). The accumulation rates in WT were 
0.38 and 0.89 NPs/min and for ΔBmrA (devoid pump) 0.53 and 1.22 NPs/min when 
incubated with 0.7 nM and 1.4 nM at 41.5 min. More intracellular NPs were seen in 
ΔBmrA than WT indicating that AgMUNH-Oflx NPs are effluxed out by BmrA 
transporter. For cells incubated with AgMUNH2 NPs the accumulation rate in WT were 
12.48 and 20.67 NPs/min and for ΔBmrA 18.29 and 28.95 NPs/min when incubated 
with 0.7 nM and 1.4 nM at 41.5 min. We can conclude that a higher number of 
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AgMUNH2 NPs were seen when compared with AgMUNH-Oflx NPs. We can conclude 
that AgMUNH-Oflx NPs are effluxed out at a much faster rate using BmrA transporter 
due to the resistance of drug even though single NPs contain 9.4x103 oflx molecules. 
These interesting findings suggest that BmrA could more effectively extrude the smaller 
nano-carriers (2.4 ± 0.7 nm) than 13.0 ± 3.1nm. Therefore, these larger nano-carriers 
could be used to effectively deliver the drug. We would further like to study 80-100 nm 
NPs functionalized with Oflx to study size-dependence.  
 
METHODS 
Reagents and Supplies 
Sodium citrate dihydrate (99%), sodium borohydride (98%), 2-mercaptoethanol 
(99%), 11-mercaptoundecylamine (MUNH2, 99%), sodium chloride, sodium phosphate, 
sodium phosphate monobasic monohydrate, tryptone, yeast extract were purchased 
from Sigma-Aldrich. 1-Ethyl-3-[3-dimethylaminopropyl]-carbodiimide hydrochloride 
(EDC, 99%) and N-hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from 
Pierce. Silver perchlorate monohydrate (99%) was purchased from Alfa Aesar. 
Ofloxacin powder (≥98%) purchased from Enzo life science. Live/dead BacLight viability 
and counting assay were purchased from Invitrogen. All reagents were used as 
received. The nanopure water (18.0 M water, Barnstead) was used to prepare all 
solutions and rinse glassware. 
 
Synthesis and Characterization of NPs  
As we described in previous papers, 13.0 ± 3.1 nm Ag NPs were synthesized by 
preparing a mixture of sodium citrate (3 mM) and NaBH4 (10 mM) in 247.5 mL of nano 
pure water, AgClO4 (2.5 mL, 10 mM, ice-cold) was quickly added. The solution turned 
yellow color within 6 mins. The solution was kept stirring at room temperature for 4 h. 
The solution was filtered using 0.2 μm membrane filters. The Ag NP solution 
immediately washed using centrifugation and characterized using UV-vis spectroscopy 
(Hitachi U2010), our dark-field single nanoparticle optical microscopy and spectroscopy 
(SNOMS). TEM samples were immediately prepared and further characterized using 
high- resolution transmission electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).  
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Our Dark-Field Optical Microscopy (DFOMS) is equipped with a dark-field optical 
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× 
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth 
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral 
Imaging System (Nuance, CRI).37,50 We explained development and application of 
DFOMS have been fully described in our previous studies. 35-37, 39-40, 42-44, 48 
 
Synthesis of AgMUNH2 NPs 
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 13.0 ± 3.1 nm Ag 
NPs solution. The solutions then were stirred for 24 h to attach MUNH2 onto the surface 
of Ag NPs via their interaction of thiol groups with NPs. The AgMUNH2 NPs were 
washed twice by nanopure water to remove excess MUNH2 using centrifugation 12,000 
rpm at 4ºC for 150 min. The AgMUNH2 NPs were immediately characterized using UV-
vis spectroscopy, DFOMS, and DLS. 
 
Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx)  
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of 
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators. 67-68 Initially, 
ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer 
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the 
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-s-
NHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol. 
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL 
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature. 
AgMUNH-Oflx NPs were washed with 50 mM PBS using centrifugation .The pellets 
were redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes and optical 
properties were characterized using UV-vis spectroscopy, DFOMS and DLS. 
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Cell Culture and Preparation 
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were 
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously 
named as ΔYvcC, mutant strain that is void of the BmrA) were provided by J. M. Jault.66 
We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of L-
broth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2) 
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured 
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured 
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10 
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in 
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used 
for the entire study. 
 
Bulk Imaging of Single NPs in Single Living Cells  
The cell suspension (OD600nm = 0.7) containing 1.4 nM and 0.7 nM AgMUNH-Oflx 
NPs and AgMUNH2 NPs were prepared. The timer was started to record the incubation 
time as the NPs were added into the cell suspension. Following NP addition, we 
transferred the mixture (1 μL) into a freshly prepared micro-chamber (using nail polish) 
every 25 min and using DFOMS we imaged the cells at eighteen representative 
locations. This approach permitted us to image the massive amount of cells ( minimum 
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells) 
for each sample to gain sufficient statistics for probing the accumulation and efflux 
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and 
plotted them versus time to measure accumulation rates of single NPs for the cells over 
time (accumulation rate = slope of the plot).  
 
Cell Viability 
At the end of each experiment, the viability of the cells was characterized using 
live/dead BacLight bacterial viability and counting assay.46 We imaged the cells using 
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green 
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm) 
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and red fluorescence cells (peak wavelength of fluorescence spectra of propidium 
iodide, λmax = 610 nm) as live and dead cells, respectively. 
 
Data Analysis and Statistics 
We acquired eighteen representative images of each cell suspension incubated 
with 1.4 or 0.7 nM NPs every 25 min (18 min for imaging and 7 min for the preparation 
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells. 
Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were 
studied over 2 h for each measurement. Each experiment was repeated three times. 
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient 
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell 
resolution. The equilibrium times of accumulation of NPs in the cells were determined at 
the times when the accumulation rates of intracellular NPs remained unchanged over 
time. The amount of accumulated intracellular NPs for each strain refers to the amount 
of intracellular NPs at the equilibrium time.  
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CHAPTER VI 
STUDY OF EFFLUX FUNCTION OF MULTIDRUG MEMBRANE TRANSPORTERS OF 
SINGLE BACILLUS SUBTILIS LIVE CELLS USING 92.0 NM DRUG NANO-
CARRIERS 
INTRODUCTION:  
Fluoroquinolone derivatives such as ofloxacin (Oflx) are used in the treatment of 
bacterial diseases such pneumonia, chronic bronchitis and urinary tract infection, 
however, bacteria have already gained resistance to these drugs.3, 52 Multidrug 
membrane resistance (MDR), poses a major problem when treating diseases such as 
infections and cancer.5, 52 MDR effluxes toxic or foreign substances out of the cell and is 
present in both prokaryotic and eukaryotic cells.3, 52 ATP-binding cassette (ABC) is one 
of the largest and most diverse super-families of membrane protein found in living 
organisms.3 It is involved in unidirectional transporter, either importing or exporting 
substrates such as sugars, ions, lipids and xenobiotic against their concentration 
gradients.1, 3-5 ABC transporter has two transmembrane binding domains (TMD) which 
selectively bind with substrates or drugs and form the passageway for substrates to 
cross membranes and consists two nucleotide-binding domains (NBD).The NBD 
hydrolyze ATP which causes the substrates to efflux out of the cell.1, 4-5  
 
The pore size of a membrane transporter is determined by x-ray 
crystallography.1, 5, 69 However, this method is limited by the crystallization of the 
membrane protein and will not provide real-time kinetic information about molecular and 
conformational changes. Current methods for the study of MDR measure the 
accumulation of radioactively labeled substances such as 14C or 3H and the fluorescent 
dyes such as ethidium bromide and Hoechst dye for uptake and efflux kinetics in both 
prokaryotic and eukaryotic cells.6-9 This approach provides the sum of accumulation 
kinetics in a cell population (bulk). However, individual single cells act independently. 
We used fluorophores and demonstrated that the efflux kinetics of single membrane 
transporters of single live cells can be studied in real time using fluorescence 
microscopy. However, radio isotopes and fluorophores do not possess size-dependent 
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physicochemical properties. This is why they are not used as pump substrates for the 
study of size-dependent efflux function of single membrane transporter in live cells.  
 
Among Noble metal nanoparticles, Gold (Au) and Silver (Ag) NPs have 
distinctive properties which can be characterized and imaged by far-field dark-field 
optical microscope with a halogen lamp illuminator.34, 38, 40, 43-44, 49-50 NPs do not undergo 
photo-bleaching or photo-blinking and the localized surface plasmon resonance (LSPR) 
spectra of single NPs highly depends upon their sizes, shapes, dielectric constants, and 
the surrounding environment.54-58 Through this information, the size of NPs in solution, 
in single live cells, and in single embryos can be determined in real time. 34, 38, 40, 43-44, 49-
50  
 
In previous studies, we used LSPR of single Ag NPs in P.aeruginosa ( a gram-
negative bacteria) and also in E.coli (a gram-negative bacteria) to study the efflux 
function.40 We further studied the size and charge dependent LSPR of single Ag NPs in 
single live Bacillus subtilis cells (a gram-positive bacterium).38-39, 65 B.subtilis was used 
as a model organism to study the efflux function since 78 ABC transporters have been 
identified in this organism.61-63  
 
In this study, we synthesized and characterized the purified Ag NPs 92.6 ± 4.4 
nm and then functionalized with Oflx. We used these nano-carriers to the study the 
efflux function of single membrane transporter in single B.subtilis cells. 
 
RESULTS AND DISCUSSION  
Synthesis of AgMUNH-Oflx (drug nano-carriers) 
 We synthesized 92.6 ± 4.4 nm Ag NPs as explained in previous papers and  
methods.42 Ag NPs were purified and then functionalized with Oflx by a two-step 
reaction process. First, the thiol group was functionalized using of MUNH2. Second, the 
carboxyl group of Oflx was linked to the amine group of MUNH2 via the peptide bond. 
We then calculated the number of Oflx attached to single NPs and found it to be 
6.5x105.60  
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Efflux mechanism of AgMUNH-Oflx and AgMUNH2 NPs in B.subtlis 
Single AgMUNH-Oflx NPs and AgMUNH2 NPs have localized surface plasma 
membrane (LSPR) spectra (colors) to distinguish between cell membranes and debris, 
which do not possess plasmonic properties. The LSPR spectra of single NPs allows us 
to track and identify intracellular and extracellular single NPs of single live cells (WT and 
ΔBmrA) using DFOMS. Representative images of dark-field optical imaging of single 
live WT cells (Fig. 36) of AgMUNH-Oflx NPs and AgMUNH2 NPs (Fig. 37) show cross 
sections of single rod-like bacterial cells. Intracellular NPs appear dimmer (Fig. 36B) for 
AgMUNH-Oflx NPs and (Fig. 37B) for AgMUNH2 NPs since dark-field illumination 
passes through the cell membrane to radiate and scatter NPs. Intracellular NPs pass 
through the membrane to reach the detector and the cell membrane absorbs and 
scatters photons resulting in lowering of the scattering intensity of NPs due to the cell 
membrane. On the other side, extracellular NPs appear brighter on the membrane and 
stick outside the cells (Fig. 36C) for AgMUNH-Oflx NPs and (Fig. 37C) for AgMUNH2 
NPs. We used LSPR distinctive feature to distinguish individual intracellular and 
extracellular NPs for the study of efflux kinetics of single membrane transporter in single 
live cells in real time.  
 
The representative LSPR spectra of single 92.6 ± 4.4 nm in Figure 36D showed 
distinctive plasmonic properties of single AgMUNH-Oflx NP with peak wavelengths 
(λmax) at 623 nm and 630 nm. If NPs were not stable they would aggregate and the size 
of NPs would increase, leading to a red shift of LSPR spectra and higher scattering 
intensity of single NPs. If Oflx or MUNH2 were released or detached from NPs surface, 
a blue shift of NPs would have observed. This was not seen, indicating that NPs are 
stable in the PBS buffer and in the cell over time. 
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Figure 36: Imaging of single intracellular 92.6 ± 4.4 nm AgMUNH-Oflx NPs in 
single living B.subtilis bacterial cells using DFOMS. 
 
 (A) The representative image of WT bacterial cells incubated with 3.7 pM AgMUNH-
Oflx NPs showing intracellular drug nano-carriers as squared. (B) Zoom-in images of 
single WT cells show (i, iii) are CCD images pseudo colors were added and (ii, iv) color 
images intracellular AgMUNH-Oflx NPs. (B) Zoom-in images of single cells show (i, iii) 
are CCD images pseudo colors were added and (ii, iv) color images extracellular 
AgMUNH-Oflx NPs. The scale bar in A and B are 5 and 2 µm, respectively. (D) LSPR 
spectra of 92.6 ± 4.4 nm AgMUNH-Oflx NPs show peak wavelength at 623 nm and 630 
nm.  
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Figure 37: Imaging of single intracellular 92.6 ± 4.4 nm AgMUNH2 NPs in single 
living B.subtilis bacterial cells using DFOMS. 
 
(A)The representative image of WT bacterial cells incubated with 3.7 pM AgMUNH2 NPs 
showing intracellular nano-carriers as squared. (B) Zoom-in images of single WT cells 
show (i, iii) are CCD images pseudo colors were added and (ii, iv) color images 
intracellular AgMUNH2 NPs. (B) Zoom-in images of single cells show (i, iii) are CCD 
images pseudo colors were added and (ii, iv) color images extracellular AgMUNH2 NPs. 
The scale bar in A and B are 5 and 2 µm. 
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Accumulation Rates of Single AgMUNH-Oflx and AgMUNH2 NPs in Single Live 
Cells 
The accumulation of single NPs were studied in two strains of B.subtilis live cells, 
WT cells which normally express of BmrA and ΔBmrA cells with deletion of BmrA, in 
real time to characterize the accumulation of intracellular NPs in single cells upon the 
expression of BmrA in single live cells, to determine if BmrA are responsible for 
extrusion of 92.4 ± 4.4 nm AgMUNH-Oflx NPs out of live cells in same as drug 
molecules. 
 
The results as shown in Figure 38A show that WT cells accumulate the 
intracellular AgMUNH-Oflx NPs to the same extent as ΔBmrA for 40.5 min. As time 
proceeded we were able to see a higher number of intracellular AgMUNH-Oflx NPs in 
ΔBmrA cells whereas in WT cells the number of intracellular AgMUNH-Oflx NPs 
remained constant. The accumulation rates (slope of the plot) of intracellular AgMUNH-
Oflx NPs were 0.27 and 0.31 NPs/min for WT and ΔBmrA cells respectively for cells 
incubated with 3.7 pM at 40.5 min (Table 5). Results from Figure 39A show that WT 
cells accumulate the intracellular AgMUNH2 NPs at a slower rate over time than ΔBmrA. 
As time lapsed, a similar number of intracellular AgMUNH2 NPs was observed in both 
strains, indicating the high dependence of accumulation rate. The accumulation of 
intracellular AgMUNH2 NPs was 1.25 and 1.73 NPs/min for WT and ΔBmrA cells 
(Table5). Bacteria cells cannot do endocytosis, pinocytosis, or exocytosis and are not 
responsible for extruding the NPs. From these two results, we can conclude that 
AgMUNH-Oflx NPs are effluxed out at a faster rate leading to less accumulation of 
AgMUNH-Oflx NPs in WT when compared with ΔBmrA.  
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Figure 38: Study of efflux kinetics of BmrA membrane transporter using 92.6 ± 4.4 
nm AgMUNH-Oflx NPs. 
 
(A) Plots of number of intracellular AgMUNH-Oflx NPs in B.subtilis incubated with 3.7 
pM (a) ΔBmrA and (b) WT. (B) Plots of number of intracellular AgMUNH-Oflx NPs in 
B.subtilis incubated with 1.85 pM (a) ΔBmrA and (b) WT. 
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Figure 39: Study of efflux kinetics of BmrA membrane transporter using 92.6 ± 4.4 
nm AgMUNH2 NPs. 
 
 (A) Plots of number of intracellular AgMUNH2 NPs in B.subtilis incubated with 3.7 pM 
(a) ΔBmrA and (b) WT (B) Plots of number of intracellular AgMUNH2 NPs in B.subtilis 
incubated with 1.85 pM (a) ΔBmrA and (b) WT. 
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Study of Concentration-Dependent Accumulation Rates of Single AgMUNH-Oflx 
NPs and AgMUNH2 NPs in Single Live Cells 
We studied the concentration-dependence of accumulation rates of single 
AgMUNH-Oflx NPs and AgMUNH2 NPs to determine how NPs enter the cells and how 
they passively diffuse into cells, similar to conventional pump substrates like antibiotics. 
The results in Figure 38, Figure 39 and Table 5 show that the intracellular NPs in single 
live cells highly depend on NP concentration for both strains (WT and ΔBmrA). The 
number of intracellular NPs increases along with the NP concentration at given 
incubation time. The number of intracellular NPs in WT increases at a slower rate than 
ΔBmrA. As the concentration of AgMUNH-Oflx NPs increased from 1.85 pM to 3.7 pM , 
the number of intracellular AgMUNH-Oflx NPs increased from 9 to 21 in WT during 41.5 
min with an accumulation rates of 0.09 to 0.27 NPs/min respectively. Whereas in 
ΔBmrA the number of intracellular AgMUNH-Oflx NPs increased from 16 to 24 during 
41.5 min with an accumulation rate 0.19 to 0.31 NPs/min respectively. We also saw 
concentration dependence in cells incubated with AgMUNH2 NPs, when the 
concentration increased from 1.85 pM to 3.7 pM, the number of intracellular AgMUNH2 
NPs increased from 72 to 98 in WT with an accumulation rate of 0.9 to 1.25 NPs/ min. 
In ΔBmrA intracellular NPs increased from 69 to 149 NPs with accumulation rate of 0.83 
to 1.7 NPs/min. 
 
These results suggest that NPs are transported from the outside to the inside of 
the cell by passive diffusion which is similar to antibiotics. They also extrude the NPs 
outside of WT cells, leading to a lower accumulation of intracellular NPs than ΔBmrA.  
 
From Figure 40Aa and 40Ab WT cells incubated with (i) AgMUNH-Oflx NPs and 
(ii) AgMUNH2 NPs at 3.7 pM and 1.85 pM concentration respectively. From Figure 40 
and Table 5 we can conclude that AgMUNH-Oflx NPs are effluxed out at a faster rate 
than AgMUNH2 NPs. This has been observed in ΔBmrA cells in Figure 40Bc and 40Bd 
as well as.  
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Figure 40: Study of concentration-dependent accumulation kinetics of Single 92.6 
± 4.4 nm AgMUNH-Oflx NPs and AgMUNH2 NPs in single live cells.  
 
Plots of number of intracellular NPs in (A) WT and (B) ΔBmrA cells that were incubated 
with (a, c) (i) 3.7 pM AgMUNH-Oflx NPs, (ii) 3.7 pM AgMUNH2 NPs (b, d) (i) 1.85 pM 
AgMUNH-Oflx NPs , (ii) 1.85 pM AgMUNH2 NPs .The points represent the sum of three 
repeated experiments. 
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Table 5: Study of Accumulation Rates and Number of Intracellular Single NPs in Single 
Live Cells 
 
 
a Diameter of Ag NPs measured by TEM; 
b Accumulation rates (slopes of plots) of the NPs in 900 live cells over 41.5 min (Figure 
40); 
c Number of intracellular NPs accumulated in 900 live cells at 41.5 min incubation 
 
 
 
 
It can be concluded that NPs functionalized with a drug molecules are effluxed 
out at a much faster rate, leading to lower accumulation rate when compared with 
AgMUNH2 NPs. The diffusion rates of NPs into the cells highly depend upon 
concentration gradient and type of molecule attached to NPs whereas as efflux out of 
cells is an energy driven (ATP) process.  
 
Characterization of Viability of Single Cells  
The viability of single cells plays a major role in accumulation studies since NPs 
will accumulate more in disintegrated or dead cells which leading to wrong conclusions. 
Hence it is important to know the viability of cells hence we used live/dead BacLight 
assay which uses two nucleic acid stains. SYTO9 (λmax = 520 nm) a green fluorescent 
to stain live cells and propidium iodide (λmax = 610 nm) red fluorescent which stain 
disintegrated and dead cells. Green fluorescence cells are counted as live cells and red 
fluorescence cells as are counted as dead cells.  
Diameter  
(nm)a 
C NPs 
(pM) 
NPs 
Accumulation  
Rate (NPs min-1)b 
Number of 
Intracellular NPs 
(min)c 
WT ΔBmrA WT Δ BmrA 
92.6±4.4 
3.7  
AgMUNH-Oflx 0.27 0.31 21 24 
AgMUNH2 1.25 1.73 98 149 
1.85  
AgMUNH-Oflx 0.09 0.19 9 16 
AgMUNH2 0.90 0.83 72 69 
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Figure 41: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay.  
 
(a)  Dark-field optical image and (b) fluorescence image of single bacterial cells (A) 
ΔBmrA (B) WT cells, incubated with 3.7 pM AgMUNH-Oflx NPs over the duration of 
each experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, 
indicating that cells are viable. (C) Plots of percentage of viable cells incubated with (a, 
b) 3.7 pM nM AgMUNH-Oflx NPs and (c, d) 1.85 pM AgMUNH-Oflx NPs, indicate that 
99-100% of the cells are alive. Minimum 300 cells were assayed and analyzed. The 
scale bar is 5 µm. 
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Figure 42: Characterization of the viability of single bacterial cells using live/dead 
Baclight viability and counting assay. 
 
(a)  Dark-field optical image and (b) fluorescence image of single bacterial cells (A) 
ΔBmrA (B) WT cells, incubated with 3.7 pM AgMUNH2 NPs over the duration of each 
experiment for 2 h, emit the green fluorescence (λmax = 520 nm) of SYTO9, indicating 
that cells are viable. (C) Plots of percentage of viable cells incubated with (a, b) 3.7 pM 
AgMUNH2 NPs and (c, d) 1.85 pM AgMUNH2 NPs, indicate that 99-100% of the cells 
are alive. Minimum 300 cells were assayed and analyzed. The scale bar is 5 µm. 
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WT and ΔBmrA cells were incubated with AgMUNH-Oflx NPs and AgMUNH2 
NPs for 2 h and then live/dead BacLight assay was used to measure viability at the end 
of an experiment by acquiring optical images and fluorescence images of single cells. 
Figure 41A and Figure 41B are representative images of ΔBmrA and WT respectively, 
Figure 41a is optical images and Figure 41b is green fluorescence with and without 
AgMUNH-Oflx NPs in single cells. We calculated the percentage of viable cells by 
dividing the number of live cells (green fluorescence) over a total number of cells (green 
and red fluorescence). Figure 41C indicates that 99-100% of cells are viable for both 
strains and concentration, thus indicating that AgMUNH-Oflx NPs are biocompatible. 
Figure 42A and Figure 42B are representative images of ΔBmrA and WT respectively, 
Figure 42a is optical images and Figure 42b is green fluorescence with and without 
AgMUNH2 NPs in single cells. Figure 42C indicates that 99-100% of cells are viable for 
both strains and concentrations, thus indicating that AgMUNH2 NPs are biocompatible.  
 
 
SUMMARY 
In summary, we synthesized and characterized 92.6 ± 4.4 nm Ag NPs and then 
functionalized them with Oflx via a peptide bond between the amine group of AgMUNH2 
and the carboxyl group of Oflx in order to synthesize AgMUNH-Oflx NPs. Both 
AgMUNH-Oflx and AgMUNH2 are biocompatible with WT and ΔBmrA cells up to the 
concentration of 3.7 pM. We demonstrated that nano-carriers can be used as 
photostable optical probes to study efflux kinetic in BmrA (ABC) membrane transporter 
in a single live cell. The results show high dependence on the type of carrier on the 
surface of NPs, the expression level of BmrA, and on the concentration of NPs. The 
results show fewer intracellular AgMUNH-Oflx NPs than AgMUNH2 NPs in BmrA cells 
which confirms that linking NPs with drug molecules, such as Oflx, causes them to 
efflux out much faster than AgMUNH2 NPs. As the concentration of NPs increased, a 
higher numbers of intracellular NPs were observed. When comparing strains, the WT 
has a smaller number of intracellular NPs when compared with ΔBmrA cells (devoid of 
BmrA) indicating strain dependence and that, this can serve in drug delivery. In this 
study, we functionalized 6.4x105 Oflx molecules on the surface of NPs.  
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METHODS 
Reagents and Supplies 
Silver nitrate, sodium citrate dihydrate (99%),Sodium chloride, sodium 
phosphate, sodium phosphate monobasic monohydrate, 2-mercaptoethanol (99%), 11-
mercaptoundecylamine (MUNH2, 99%), were purchased from Sigma-Aldrich. 1-Ethyl-3-
[3-dimethylaminopropyl]-carbodiimide hydrochloride (EDC, 99%) and N-
hydroxysulfosuccinimide (sulfo-NHS, 98.5%) were purchased from Pierce. Silver 
perchlorate monohydrate (99%) was purchased from Alfa Aesar. Ofloxacin powder 
(≥98%) purchased from Enzo life science. Tryptone, yeast extract, and NaCl are 
purchased from sigma-Aldrich and live/dead BacLight viability and counting assay were 
purchased from Invitrogen. All reagents were used as received. The nanopure water 
(18.0 M water, Barnstead) was used to prepare all solutions and rinse glassware. 
 
Synthesis and Characterization of NPs  
Synthesize 92.6 ± 4.4 nm Ag NPs, sodium citrate (10 mL, 34 mM) was added 
into a refluxing (100 ºC) stirring AgNO3 (500 mL, 3.98 mM) solution which further was 
stirring for additional 35 min.42 The heating was stopped to allow the solution to cool 
down to room temperature without stirring. Additional sodium citrate (2.5 mM) was 
added to the NPs solution for stability purpose. The solution was filtered through 0.22 
µm membrane and purified by washing three times with nanopure water using 
centrifugation. Characterized using UV-vis spectroscopy (Hitachi U2010), our dark-field 
single nanoparticle optical microscopy and spectroscopy (SNOMS), and dynamic light 
scattering (DLS) (Nicomp 380ZLS particle sizing system). TEM samples were 
immediately prepared and further characterized using high-resolution transmission 
electron microscopy (HRTEM) (FEI Tecnai G2 F30 FEG).  
 
Our  Dark-field Optical Microscopy (DFOMS) is equipped with a dark-field optical 
microscope, which includes a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× 
objective (Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm) with a depth 
of field (focus) of 190 nm, a CCD camera (Micromax, Roper Scientific) and Multispectral 
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Imaging System (Nuance, CRI). 37, 50 We explained development and application of 
DFOMS have been fully described in our previous studies. 35-37, 39-40, 42-44, 48 
 
Synthesis of AgMUNH2 NPs 
MUNH2 (100 mM) in 1 mL ethanol was added to 100 mL of 92.6 ± 4.4 nm Ag 
NPs solution. The solutions then were stirred for 24 h to attach MUNH2 onto the surface 
of Ag NPs via their interaction of thiol groups with NPs. The AgMUNH2 NPs were 
washed twice by nanopure water to remove excess MUNH2 using centrifugation 25,000 
rpm at 4ºC for 20 min. The AgMUNH2 NPs were immediately characterized using UV-
vis spectroscopy, DFOMS and DLS. 
 
Synthesis of AgMUNH-Ofloxacin NPs (AgMUNH-Oflx)  
An amine group of AgMUNH2 NPs was conjugated to a carboxyl group of 
ofloxacin via a peptide bond using EDC and sulfo-NHS as mediators. 67-68 Initially, 
ofloxacin powder was dissolved in 0.5 M HCl and diluted to 10 mM using MES buffer 
(50 mM, pH 5.0). EDC (30 μmol) and sulfo-NHS (150 μmol) were added into the 
ofloxacin solution (3 mL, 50 mM) which then was kept stirring for 40 min allowing Oflx-s-
NHS esters to form. The reaction was stopped by adding 10 μL of 2-mercaptoethanol. 
To link AgMUNH2 with Oflx-s-NHS, 1 mL Oflx-s-NHS esters were mixed with 100 mL 
AgMUNH2 of each different NPs size using a rotary shaker for 3 h at room temperature. 
AgMUNH-Oflx were washed with 50 mM PBS using centrifugation .The pellets were 
redispersed in 50 mM PBS and stored at 4ºC for future use. The sizes and optical 
properties were characterized using UV-vis spectroscopy, DFOMS and DLS. 
  
             
Cell Culture and Preparation 
The Bacillus subtilis cell lines using in this study are as follows: WT (BmrA) were 
purchased from Bacillus Genome Stock Center (BGSC), while ΔBmrA (previously 
named as ΔYvcC, a mutant strain that is void of the BmrA) were provided by J. M. 
Jault.66  
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We pre-cultured the cells in an Erlenmeyer flask (250 mL) containing 20 mL of L-
broth (LB) medium (1% tryptone peptone, 0.5% yeast extract, and 0.5% NaCl, pH = 7.2) 
in a shaker (MaxQ 5000 floor-Model Shaker) (160 rpm, 37C) for 12 h. We then cultured 
the cells (WT and ΔBmrA) in the LB medium for another 8 h. We harvested the cultured 
cells using centrifugation (Beckman Model J2-21,JA-14 rotor, at 7000 rpm, 23°C, 10 
min), washed the cells in PBS buffer three times, and finally re-suspended the cells in 
PBS buffer. The final concentration of the cells was adjusted to OD600 nm = 0.7, and used 
for the entire study. 
 
Bulk Imaging of Single NPs in Single Living Cells  
The cell suspension (OD600nm = 0.7) containing 3.7 pM and 1.85 pM AgMUNH-
Oflx NPs and AgMUNH2 NPs were prepared. The timer was started to record the 
incubation time as the NPs were added into the cell suspension. Following NP addition, 
we transferred the mixture (1 μL) into a freshly prepared micro-chamber (using nail 
polish) every 25 min and using DFOMS we imaged the cells at eighteen representative 
locations. This approach permitted us to image the massive amount of cells ( minimum 
of 10 cells per location for every 18 locations we usually get 18*10=180 bacteria cells) 
for each sample to gain sufficient statistics for probing the accumulation and efflux 
kinetics of bulk cells at single cell resolution. We determined intracellular NPs and 
plotted them versus time to measure accumulation rates of single NPs for the cells over 
time (accumulation rate = slope of the plot).  
 
Cell Viability 
At the end of each experiment, the viability of the cells was characterized using 
live/dead BacLight bacterial viability and counting assay. We imaged the cells using 
dark-field optical microscopy and epi-fluorescence microscopy, and counted the green 
fluorescence cells (peak wavelength of fluorescence spectra of SYTO9, λmax = 520 nm) 
and red fluorescence cells (peak wavelength of fluorescence spectra of propidium 
iodide, λmax = 610 nm) as live and dead cells, respectively. 
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Data Analysis and Statistics 
We acquired eighteen representative images of each cell suspension incubated 
with 3.7 or 1.85 pM NPs every 25 min (18 min for imaging and 7 min for the preparation 
of slide) for 2 h to study accumulation rates of intracellular NPs in single living cells. 
Therefore, a minimal of ~180 cells was imaged every 25 min, and 900 cells were 
studied over 2 h for each measurement. Each experiment was repeated three times. 
Thus, 2700 cells were studied for each sample, which allowed us to gain sufficient 
statistics for probing accumulation rates and efflux kinetics of bulk cells at single cell 
resolution. The equilibrium times of accumulation of NPs in the cells were determined at 
the times when the accumulation rates of intracellular NPs remained unchanged over 
time. The amount of accumulated intracellular NPs for each strain refers to the amount 
of intracellular NPs at the equilibrium time.  
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CHAPTER VII 
CONCLUSION 
 
In summary, this dissertation presents our study of development of Ag NPs for 
the study of multidrug ABC membrane transporters (e.g., MsbA and BmrA) in single live 
cells and for design of drug nano-carriers to achieve effective therapy, aiming to 
understand and overcome MDR. We have studied and found the high dependence of 
efflux kinetics of membrane transporters of single live cells upon the sizes of single Ag 
NPs and single drug nano-carriers. We have designed and studied the high 
dependence of inhibitory effects of drug nano-carriers against bacterial cells (e.g., two 
model organisms such as E.coli, B.subtilis). The most significant findings in each 
chapter are summarized below.  
 
As we described in Chapter II, we synthesized and characterized purified and 
nearly uniform spherical Ag NPs (12.3 ± 1.8 nm in diameter) to study real-time efflux 
function of ABC membrane transporters in single live cells. We developed new imaging 
approach, such as DFOMS, to study the efflux kinetics and functions of ABC membrane 
transporters of single live cells. We used distinctive LSPR spectra of single Ag NPs to 
identify and track single NPs in and out of single live cells, and to study the efflux 
function of single MsbA membrane transporters in single live cells in real time. We 
found that Ag NPs were biocompatible with single live cells and single Ag NPs can be 
used to study the efflux kinetics of single MsbA membrane transporters in single live 
cells in real time. We found a high-dependent accumulation rates of single Ag NPs in 
single live cells upon the concentration of NPs and the presence of the pump inhibitor 
(orthovanadate), suggesting that NPs enter cells via passive diffusion, similar to 
antibiotics (pump substrates), and extruded out of the cells by MsbA transporters. 
These results demonstrate that single plasmonic NPs can serve as unique sized-
dependent molecular imaging probes to study efflux functions of single membrane 
transporters in single live cells in real-time.  
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As described in Chapter III, we synthesized and characterized three different 
sized Ag NPs (2.4 ± 0.7 nm, 13.0 ± 3.1 nm and 92.6 ± 4.4 nm), functionalized them with 
monolayer of MUNH2, and linked them with antibiotics (Oflx) via two-step reaction 
process. First thiol group is used to attach monolayer of MUNH2 molecules to produce 
AgMUNH2 NPs, and in step 2, carboxyl group of ofloxacin (Oflx) is covalently 
conjugated with the amine group of MUNH2 on the NPs via the peptide bond. We 
determined the conjugation ratio (the number of Oflx molecules attached to a single NP) 
of 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm as 8.6x102, 9.4x103, and 6.5x105, 
respectively. We studied size-dependent biocompatibility and toxicity of drug nano-
carriers (AgMUNH-Oflx NPs) in bacterial cells (B.subtilis). We found size-dependent 
inhibitory effects of drug nano-carriers against the bacteria cells, and the smaller drug 
nano-carriers are much more biocompatible than the larger drug nano-carriers. In other 
words, the larger drug nano-carriers show higher inhibitory effects against the bacterial 
cells. For example, 2.4 ± 0.7 nm AgMUNH-Oflx NPs is more biocompatible than 13.0 ± 
3.1 nm AgMUNH-Oflx NPs. Further, 92.6 ± 4.4 nm AgMUNH-Oflx NPs show higher 
inhibitory effects than 13.0 ± 3.1 nm AgMUNH-Oflx NPs. These results demonstrate that 
2.4 ± 0.7 nm AgMUNH-Oflx NPs can be used for probing of efflux kinetics and functions 
of single ABC membrane transporters in single live cells, while the larger drug nano-
carriers (92.6 ± 4.4 nm AgMUNH-Oflx NPs) could be used to enhance efficacy of 
antibiotics against bacteria. We used these drug nano-carriers to study efflux functions 
of ABC (BmrA) transporters in single live cells (two strains of B.subtilis), WT (normal 
expression of BmrA) and ∆BmrA (deletion of BmrA), as described in Chapters IV-VI. 
 
As we described in Chapter IV, we used the smallest drug nano-carriers (2.4 ± 
0.7 nm AgMUNH-Oflx NPs) to study the efflux kinetics and functions of ABC (BmrA) 
transporters in single live cells (B.subtilis). Interestingly, we did not find the significant 
dependence of accumulation kinetics of such small drug nano-carriers upon the dose of 
the drug nano-carriers (0.7 and 1.4 nM) for the WT strain, while we observed the 
significant dependence of accumulation kinetics of the drug nano-carriers upon the dose 
of the drug nano-carriers (0.7 and 1.4 nM) for the ΔBmrA strain. The results show the 
high dependence of accumulation kinetics of the drug nano-carriers upon the 
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expression of BmrA in single B.subtilis live cells, suggesting that these small drug nano-
carriers passively diffused into the live cells and were extruded out of the cells by BmrA, 
similar to antibiotics.  
 
 As we presented in Chapter V, we used slightly larger drug nano-carriers (13.0 ± 
3.1 nm AgMUNH-Oflx NPs) to study the efflux kinetics and functions of BmrA 
transporters in single live cells (B.subtilis). Remarkably, unlike the smaller 2.4 ± 0.7 nm 
drug nano-carriers, we found the high dependence of accumulation kinetics of the drug 
nano-carriers upon the dose of the drug nano-carriers (0.7 and 1.4 nM) for both strains 
of BmrA (WT, ΔBmrA) and the expression of BmrA in single live cells. The findings 
further suggest that the drug nano-carriers passively diffused into the live cells and were 
extruded out of the cells by BmrA, similar to antibiotics. Moreover, the results suggest 
that the BmrA could more effectively extrude the smaller drug nano-carriers (2.4 ± 0.7 
nm) than the larger drug nano-carriers (13.0 ± 3.1 nm). Therefore, the smaller drug 
nano-carriers could be used to study the efflux function of BmrA membrane transporters 
in single live cells, while the large drug nano-carriers could be used to effectively deliver 
antibiotics that could overcome MDR and enhance antibiotics efficacy.  
 
As we described in Chapter VI, we used the largest drug nano-carriers (92.6 ± 
4.4 nm) to study the efflux kinetics and function of BmrA membrane transporter in single 
live cells (B.subtilis). Interestingly, like 13.0 ± 3.1 nm drug nano-carriers, we found the 
high dependence of accumulation kinetics of the nano-carriers upon the dose of the 
drug nano-carriers (1.85 and 3.7 pM) for both strains of BmrA (WT, ΔBmrA), while 
insignificant dependence of accumulation kinetics of the drug nano-carriers upon the 
expression of BmrA in single live cells. The results demonstrate that such larger nano-
carriers passively diffused into the live cells and were ineffectively extruded out of the 
cells by BmrA. The largest drug nano-carriers (92.6 ± 4.4 nm) could be least effectively 
extruded out of the cells while the smallest drug nano-carriers (2.4 ± 0.7 nm) could be 
most effectively extruded out of the cells. Taken together, our study further 
demonstrates that the smaller drug nano-carriers could be used to study the efflux 
function of BmrA membrane transporters in single live cells, while the large drug nano-
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carriers could be used to effectively deliver antibiotics that could overcome MDR and 
enhance antibiotics efficacy.  
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APPENDIX 
When using nanoparticles, standard laboratory practices regarding the use 
of hazardous chemicals are followed. The following work practice is required when 
handling nanoparticles to reduce potential exposure and ensure safe conditions in 
our laboratories. Lab coats must be worn or arm sleeves are required where high 
levels of exposure or splashes of solutions containing nanoparticles are 
anticipated. Eye protection, where appropriate to the tasks performed is required. 
This may include safety glasses, face shields, and/or chemical splash goggles. 
Gloves (disposable) are worn at all times when handling nanomaterials. 
Appropriate personal clothing is required in all laboratories. Long pants and closed 
toed shoes are required. Hand washing facilities are provided in all labs and hand 
washing must be performed after handling nanomaterials. All solutions are 
disposed of as hazardous waste following established guidelines of the 
environmental health and safety office. 
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